rfhg_104954.1

Basic information about the TSS

---

TSS ID: rfhg_104954.1 Species: human Chr: chr8		Start: 26577467 End: 26577488 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D4074439,EH38E2619095)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000311151.9:355 GeneID: 1808 HGNC/MGI_ID: HGNC:3014 UniProt_ID: Q16555 Nearer transcript ids and distances: ENST00000493789.6:-405 BX647115:406 BC067109:450 U97105:452 LF210129:452 MA445706:452 NM_001386.6:457 AK223557:471 BC056408:480 D78013:491 view more...

Gene_name: dihydropyrimidinase like 2 Gene_symbol: DPYSL2 Gene_synonyms: CRMP2 DHPRP2 DRP-2 DRP2 Gene_source: HGNC:3014

TATA-Box annotation

---

Distance to TSS:	-468
Nearest PromoterID:	NM_001386
Entrez ID:	1808
Nearest Unigene:	Hs.593187
Nearest Refseq:	NM_001386
Nearest Ensembl:	ENSG00000092964
Gene Name:	dihydropyrimidinase like 2
Gene Alias:	CRMP-2|CRMP2|DHPRP2|DRP-2|DRP2|N2A3|ULIP-2|ULIP2
Gene Type:	protein-coding
CpG%:	0.095238
GC%:	0.636364
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DPYSL2 p2@DPYSL2 p5@DPYSL2 p6@DPYSL2 p8@DPYSL2 p9@DPYSL2 p10@DPYSL2
Sample		p1@DPYSL2	p2@DPYSL2	p5@DPYSL2	p6@DPYSL2	p8@DPYSL2	p9@DPYSL2	p10@DPYSL2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	9.55	22.60	0.39	4.09	0.78	0.00	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	11.94	21.24	0.20	3.24	0.00	0.00	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	9.45	23.34	0.00	5.98	0.77	0.00	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	8.52	19.75	0.00	2.29	0.83	0.21	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	8.77	18.22	0.22	2.70	0.67	0.00	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	8.53	15.89	0.00	4.85	0.19	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	9.15	9.59	0.00	2.61	0.65	0.22	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	5.09	13.08	0.00	1.94	0.00	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	8.55	13.25	0.00	2.35	0.00	0.00	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	8.69	11.01	0.00	1.74	0.58	0.00	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	5.66	12.94	0.00	2.43	0.81	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	5.69	9.76	0.00	1.63	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	39.33	37.88	2.74	10.16	1.77	0.16	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	32.78	25.41	2.86	12.78	1.65	0.00	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	50.06	31.18	2.42	8.34	2.42	0.66	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	44.26	37.22	2.26	9.81	3.02	0.25	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	46.96	31.01	1.31	8.74	2.18	0.00	1.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	45.13	49.35	0.42	13.50	3.37	0.42	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	41.59	26.12	0.53	8.53	1.07	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	31.59	29.64	2.41	7.52	2.26	0.00	1.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	33.28	25.79	1.60	13.90	1.87	0.27	1.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	27.96	31.07	2.59	9.32	1.90	0.00	1.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	37.87	25.21	1.68	11.63	1.81	0.26	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	41.50	32.52	2.43	13.10	1.21	0.24	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	39.47	28.64	1.81	13.16	1.55	0.00	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	25.00	34.82	1.27	10.44	1.90	0.32	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	49.45	33.52	3.30	8.79	0.55	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	34.42	23.81	2.59	12.02	1.18	0.24	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	29.24	20.51	1.62	11.79	1.13	0.16	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	31.31	22.98	2.90	10.32	0.90	0.36	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	40.61	27.21	1.26	7.12	1.26	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	36.73	24.42	1.76	10.16	1.37	0.20	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	31.02	26.80	0.84	8.86	1.27	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	29.36	25.40	1.98	13.53	0.49	0.49	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	35.90	26.93	1.31	10.47	1.68	0.37	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	35.07	22.61	1.72	9.96	2.87	0.38	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	31.88	25.55	1.02	7.97	0.61	0.00	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	36.07	20.95	0.60	8.06	1.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	33.76	23.23	2.43	9.99	0.81	0.00	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	43.21	26.41	1.68	8.40	1.92	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	28.00	19.53	2.12	8.70	2.82	0.24	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	28.40	19.91	1.46	7.32	1.32	0.00	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	33.95	21.93	1.27	6.75	2.95	0.84	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	37.41	22.90	1.40	9.44	2.45	0.17	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	35.14	17.27	1.61	8.23	3.01	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	42.11	20.94	1.16	7.44	2.79	0.93	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	46.54	20.39	1.92	6.96	2.40	0.00	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	32.49	19.08	2.09	5.07	1.79	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	42.37	18.67	2.15	6.70	1.20	0.00	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	31.74	20.02	2.63	9.71	1.42	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	32.79	30.13	1.02	7.99	1.64	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	34.02	36.69	1.11	7.56	3.11	0.89	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	1413.21	0.00	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	31.94	37.61	1.06	5.68	1.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	25.85	28.17	0.99	7.62	1.33	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.94	127.52	0.00	9.23	1.68	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	28.47	57.41	0.46	3.21	1.38	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	23.98	39.87	1.30	6.48	1.62	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	23.45	54.28	0.64	6.10	1.61	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	23.26	77.95	2.20	5.66	0.94	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	22.56	35.96	1.41	5.64	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	19.63	26.36	1.12	6.17	3.36	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	10.35	116.24	0.80	0.00	0.00	0.00	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	13.93	33.64	1.36	2.38	0.68	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	19.17	30.54	1.62	3.25	0.97	0.32	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	18.81	35.14	0.35	3.19	1.77	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	1163.80	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	758.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	47.78	58.99	0.49	6.34	3.41	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	53.55	39.17	1.49	7.44	2.48	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	27.21	40.34	1.41	7.51	0.94	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	46.70	79.49	2.32	9.94	2.65	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	82.59	83.52	1.24	7.42	5.26	0.62	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	79.49	66.35	2.45	11.01	3.36	1.22	1.83
Adipocyte - breast, donor1	11376-118A8	128.13	106.43	19.01	4.12	3.33	7.60	0.16
Adipocyte - breast, donor2	11327-117E4	96.90	69.79	5.45	3.69	1.60	4.49	0.48
Adipocyte - omental, donor1	11473-119C6	173.79	74.68	11.32	6.11	5.85	9.03	0.51
Adipocyte - omental, donor2	11474-119C7	112.87	85.21	5.23	1.49	3.74	2.24	1.49
Adipocyte - omental, donor3	11475-119C8	145.35	103.49	5.02	7.70	2.68	4.69	1.67
Adipocyte - perirenal, donor1	11476-119C9	142.27	116.11	3.19	7.02	3.19	5.74	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	24.19	6.60	2.20	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	68.65	31.16	2.71	6.32	3.61	2.71	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	45.01	34.93	4.34	1.74	1.74	1.74	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	93.68	41.07	4.89	3.32	3.52	0.78	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	51.73	21.36	2.83	2.32	1.54	0.51	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	129.91	44.60	5.02	2.79	2.51	2.51	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	112.27	34.68	5.29	5.29	5.29	3.53	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	74.80	26.14	5.95	2.90	3.22	1.77	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	89.73	36.15	3.55	2.26	2.90	1.61	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	66.65	28.26	1.60	4.27	1.60	3.20	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	69.00	32.27	1.11	4.45	1.67	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	76.94	23.29	4.99	2.91	4.16	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	77.86	39.68	2.01	2.51	3.52	1.76	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	62.50	25.85	1.64	0.33	2.62	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	59.37	19.49	0.91	1.83	2.74	2.44	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	51.27	20.11	1.33	1.77	5.30	0.22	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	56.66	17.93	0.36	0.36	5.02	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	27.55	7.19	0.00	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	146.44	70.52	12.23	0.00	12.05	1.26	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	147.27	90.37	5.02	0.00	11.71	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	139.50	57.32	9.04	1.03	10.68	1.44	0.00
Anulus Pulposus Cell, donor1	11248-116E6	58.47	23.23	3.20	0.11	1.95	1.26	0.00
Anulus Pulposus Cell, donor2	11463-119B5	64.90	33.31	1.22	1.96	1.71	0.98	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	106.48	108.73	4.94	0.45	3.15	5.84	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	109.84	82.92	2.60	1.74	5.21	3.04	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	89.89	102.73	2.14	2.14	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	96.55	92.96	6.88	0.60	3.59	4.48	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	97.38	78.41	5.06	0.00	5.06	3.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	97.03	105.61	3.30	2.64	1.32	3.96	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	85.45	82.85	4.22	1.30	4.22	1.62	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	85.44	107.28	6.80	1.94	2.91	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	100.96	90.86	4.75	2.97	3.56	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	97.55	98.68	4.52	0.38	3.39	4.52	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	82.00	93.61	5.08	0.00	5.81	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	67.70	110.33	7.52	1.25	3.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	75.28	24.38	6.26	1.81	2.47	2.64	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	90.08	103.72	2.73	2.73	4.09	4.09	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	98.32	58.21	6.63	1.81	4.52	2.11	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	81.98	79.30	6.97	2.68	4.29	4.29	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	99.76	81.81	9.07	2.08	3.21	2.08	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	112.53	80.45	4.54	1.07	3.47	0.80	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	86.82	88.77	3.90	3.90	2.93	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	88.07	76.79	7.80	0.66	4.81	3.15	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	76.85	78.05	2.40	0.00	3.60	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	74.34	95.58	0.00	0.00	7.08	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	100.17	78.56	7.89	1.72	3.26	1.72	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	83.90	104.87	0.00	4.19	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	100.00	110.19	4.37	1.46	4.37	4.85	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	94.86	77.03	7.59	1.52	3.42	3.04	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	96.91	99.33	4.85	3.63	2.42	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	87.22	102.04	2.28	2.85	4.56	2.85	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	98.98	75.46	4.92	2.35	2.99	1.92	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	87.75	70.97	5.16	2.58	2.06	2.06	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	92.43	83.05	2.82	1.88	4.22	0.94	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	100.64	91.96	6.43	2.89	1.93	0.96	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	95.60	92.04	4.99	1.43	2.14	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	78.38	91.25	4.09	2.34	1.17	4.09	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	106.58	101.16	3.61	0.90	6.02	1.81	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	99.79	129.49	4.75	1.19	1.19	4.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	93.07	81.37	2.54	1.53	5.59	3.56	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	98.31	87.36	7.64	2.04	3.31	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	71.16	84.50	2.54	1.91	2.54	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	94.07	79.83	5.61	2.16	4.32	3.02	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	99.07	90.81	9.10	2.54	3.81	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	99.75	89.31	4.64	4.35	2.90	0.87	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	98.25	106.76	4.72	1.89	5.67	7.56	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	88.83	80.19	5.93	1.02	2.71	1.36	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	90.34	101.92	9.27	0.00	11.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	59.15	90.84	6.34	2.11	4.23	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	106.99	84.05	7.29	1.29	3.43	1.93	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	101.68	93.86	4.81	1.20	4.21	2.41	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	87.48	115.18	7.29	3.64	5.83	2.19	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	90.11	72.41	4.14	1.15	3.22	2.30	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	91.81	130.07	2.55	5.10	5.10	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	84.91	58.47	6.10	1.53	3.81	1.27	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	110.03	95.79	7.64	0.62	4.95	2.68	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	109.24	78.03	2.45	1.84	2.14	3.98	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	107.55	107.07	4.78	0.96	7.65	4.78	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	98.67	96.46	6.43	2.00	3.55	3.33	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	120.54	138.85	7.63	0.00	3.05	6.10	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	84.74	95.27	2.77	2.77	2.22	1.66	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	99.30	81.82	6.88	2.12	3.44	1.32	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	114.12	105.40	2.91	1.82	5.45	4.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	156.59	50.60	4.05	1.11	13.02	1.35	1.11
Astrocyte - cerebellum, donor2	11580-120F5	107.66	41.08	2.57	0.68	5.99	0.68	0.51
Astrocyte - cerebellum, donor3	11661-122F5	91.45	48.45	4.61	6.92	5.24	1.05	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	192.77	114.68	16.03	7.32	11.50	2.44	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	165.66	76.36	8.41	4.85	9.38	1.29	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	205.99	75.03	8.80	7.31	9.10	2.54	2.24
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	139.11	29.47	1.38	0.00	16.40	0.11	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	150.96	32.95	1.75	0.00	17.16	0.13	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	142.13	32.09	1.59	0.00	15.82	0.46	0.00
Basophils, donor1	12241-129G9	27.20	7.58	1.05	0.00	1.31	0.26	0.00
Basophils, donor2	12242-129H1	42.93	7.58	2.89	0.00	1.08	1.44	0.00
Basophils, donor3	12243-129H2	66.59	20.43	3.38	0.15	2.94	0.59	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	7.98	1.94	0.00	0.00	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	8.69	2.74	0.00	0.00	0.91	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	7.17	0.00	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	7.53	3.14	0.00	0.00	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	17.05	4.37	0.21	0.00	1.87	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	17.96	5.30	0.46	0.00	1.84	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	15.30	8.28	0.36	0.00	1.08	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	35.97	16.28	3.09	0.00	4.33	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	30.04	10.95	1.40	0.00	2.10	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	21.42	15.99	2.24	0.00	1.28	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	32.69	22.54	2.82	1.13	1.13	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	51.41	24.13	0.37	0.00	1.86	0.93	0.00
CD14+ Monocytes, donor3	11381-118B4	48.52	34.47	2.85	0.00	1.98	0.66	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	95.67	26.04	3.11	1.98	5.38	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	127.37	25.78	3.41	3.03	5.69	1.52	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	114.73	21.37	4.93	1.64	5.59	0.99	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	82.39	25.87	2.75	0.00	3.18	1.01	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	42.55	13.58	0.30	0.00	1.51	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	70.59	21.32	2.13	0.00	3.55	1.42	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	49.55	16.74	0.50	0.00	2.34	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	23.18	6.35	0.28	0.00	1.38	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	18.59	8.68	0.25	0.50	0.99	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	31.33	11.16	0.20	0.00	1.37	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	34.72	10.86	0.89	0.18	1.96	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	17.41	5.66	0.44	0.22	0.87	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	26.46	13.58	1.17	0.23	0.94	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	26.40	10.56	0.53	0.00	1.06	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	21.08	9.98	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	35.10	12.49	0.89	0.00	1.93	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	19.76	6.39	0.60	0.00	1.20	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	16.03	3.33	0.00	0.21	1.67	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	42.10	22.65	0.92	0.00	1.37	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	12.89	3.17	0.45	0.23	1.36	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	18.77	8.29	0.44	0.00	1.75	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	78.55	23.13	0.81	0.54	2.42	0.81	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	60.19	16.92	0.70	0.00	2.62	0.35	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	63.54	16.83	1.26	0.42	2.95	0.84	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	15.25	7.16	0.37	0.18	1.10	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	20.78	3.87	0.00	0.00	1.06	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	13.16	5.26	0.88	0.00	0.88	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	23.37	14.82	0.17	0.00	1.22	0.52	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	27.13	19.33	1.12	0.00	1.49	0.74	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	21.55	4.74	0.43	0.00	1.08	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	43.82	11.06	2.46	0.00	2.46	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	8.11	2.78	0.93	0.46	0.23	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	11.14	3.02	0.70	0.00	0.46	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	88.93	27.25	1.53	0.00	5.23	0.65	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	145.30	28.41	3.23	0.00	4.62	0.92	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	73.43	35.52	1.95	0.00	3.90	1.30	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	144.04	29.90	5.14	0.16	5.14	2.02	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	136.57	47.85	4.02	0.00	4.54	3.32	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	123.08	25.42	8.47	0.00	3.57	2.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	49.76	18.12	0.00	0.00	3.57	0.77	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	73.33	19.76	1.10	0.00	4.61	1.32	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	53.27	22.53	1.47	0.00	5.05	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	10.16	8.13	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	27.80	4.07	0.00	0.00	2.71	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	23.82	9.32	1.04	1.04	2.07	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	11.73	9.06	0.00	0.00	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	15.55	4.82	0.00	0.00	1.07	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	23.87	2.11	0.00	0.70	2.81	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	18.82	3.92	0.78	0.00	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	22.41	1.32	0.00	0.00	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	24.66	5.75	0.82	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	22.49	8.71	0.73	0.00	1.45	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	22.21	3.03	0.00	0.00	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	5.66	1.21	0.00	0.00	1.21	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.80	2.40	0.00	0.00	0.80	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	14.06	3.01	1.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	8.99	1.69	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	25.55	13.53	2.25	0.00	1.13	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	21.42	8.12	2.25	0.00	2.03	0.45	0.00
CD4+ T Cells, donor1	11225-116C1	10.71	4.64	0.71	0.00	2.14	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	13.47	7.35	0.61	0.00	1.22	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	17.69	10.98	0.30	0.00	0.30	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	91.37	10.46	4.08	0.00	4.85	1.53	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	76.14	26.28	3.37	0.00	6.29	0.67	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	87.10	21.85	2.01	0.00	4.89	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	16.59	3.32	0.00	0.00	1.42	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	10.53	4.92	0.00	0.00	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	3.30	0.00	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	44.37	8.09	1.45	0.00	3.18	0.29	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	57.96	34.74	1.02	0.00	3.90	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	42.56	27.08	2.74	0.00	4.35	0.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	39.90	12.55	0.90	0.00	2.69	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	35.99	14.67	0.35	0.00	2.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	39.60	11.44	2.20	0.00	2.20	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	69.99	21.93	0.42	0.00	5.06	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	53.60	39.68	3.74	0.00	3.32	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	47.78	42.43	2.34	0.00	3.68	1.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	23.66	4.08	0.27	0.00	1.09	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	35.91	6.43	0.54	0.00	4.29	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	16.14	3.59	0.00	0.00	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	58.97	12.79	4.08	0.00	3.34	1.48	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	29.89	10.40	3.25	0.22	2.17	0.65	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	24.59	9.46	2.52	0.00	2.52	0.63	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	17.19	4.55	1.01	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	24.26	3.47	2.17	0.00	0.87	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	21.35	6.10	2.18	0.00	1.74	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	27.22	4.95	0.99	0.00	1.98	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	16.62	3.69	1.85	0.00	2.77	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	20.94	4.19	1.40	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	41.54	4.43	1.11	0.00	1.94	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	43.43	3.44	1.23	0.00	1.72	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	32.34	9.24	3.08	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	30.44	6.09	2.86	0.00	1.07	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	19.39	4.15	1.38	0.00	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	11.13	1.96	0.98	0.00	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	10.89	6.38	0.00	0.00	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	10.86	4.29	0.25	0.00	0.25	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	33.95	33.26	1.38	1.84	0.46	0.69	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	27.80	23.01	0.24	0.48	2.64	0.24	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	32.28	20.25	1.09	1.37	1.09	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	30.92	37.83	0.30	0.30	2.40	0.00	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	30.48	38.16	1.44	0.48	0.96	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	33.65	27.51	0.45	0.68	2.05	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	41.07	46.50	1.52	1.74	2.17	0.22	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	42.11	55.01	1.84	1.84	2.37	1.05	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	41.74	38.93	0.94	1.17	1.41	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	36.53	46.79	0.91	2.42	1.21	0.91	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	48.80	45.61	0.29	0.58	0.87	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	34.64	30.91	0.27	1.07	4.26	0.53	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	44.65	41.15	0.44	1.75	0.88	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	36.43	51.92	1.37	2.28	2.28	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	70.11	57.43	0.00	2.98	6.71	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	32.41	42.50	0.36	1.80	4.68	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	32.22	42.58	0.86	1.73	0.86	0.29	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	33.23	30.40	0.47	0.71	1.18	0.00	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	28.20	34.54	0.00	2.22	3.17	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	27.99	44.29	0.62	0.62	1.85	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	28.85	33.34	0.00	0.96	2.56	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	35.19	35.19	0.38	3.06	1.15	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	33.50	42.17	0.79	1.58	1.18	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	31.01	40.85	0.00	3.03	3.78	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	22.48	36.13	0.00	2.41	2.41	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	37.07	36.37	0.70	1.40	2.10	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	19.03	26.05	3.01	2.00	3.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	208.36	87.73	9.14	9.14	12.79	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	83.50	49.90	1.98	8.89	4.45	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	88.61	51.98	8.10	13.58	5.16	1.89	1.58
Chondrocyte - de diff, donor1	11261-116G1	123.76	124.11	9.71	2.77	3.81	3.81	0.69
Chondrocyte - de diff, donor2	11338-117F6	67.88	52.95	9.60	17.77	3.91	3.20	0.36
Chondrocyte - de diff, donor3	11410-118E6	64.29	72.14	8.42	8.42	1.37	2.73	0.57
Chondrocyte - re diff, donor2	11339-117F7	88.63	27.75	12.53	2.69	1.79	7.16	0.00
Chondrocyte - re diff, donor3	11411-118E7	71.98	26.69	4.85	0.81	1.62	5.66	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	122.91	35.35	8.26	0.57	6.08	2.07	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	85.93	41.26	3.42	1.28	5.13	1.28	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	74.43	29.29	4.60	1.15	4.25	0.71	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	195.60	47.13	27.97	8.99	9.17	6.60	2.57
Corneal Epithelial Cells, donor1	11526-119I5	8.34	2.85	0.00	0.00	1.76	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	6.83	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	7.67	2.81	0.51	0.00	1.28	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	254.25	55.80	4.79	0.00	14.53	0.66	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	190.51	53.62	1.58	0.00	15.14	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	186.34	17.25	10.35	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	133.37	41.14	3.02	0.00	8.53	0.43	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	128.80	43.05	5.12	0.00	6.83	1.02	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	122.09	18.28	5.22	0.00	1.96	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	129.70	11.61	0.97	0.00	1.45	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	46.36	28.02	4.00	19.35	3.00	1.00	3.34
Endothelial Cells - Aortic, donor1	11263-116G3	72.76	14.08	4.69	14.08	1.76	1.17	2.35
Endothelial Cells - Aortic, donor2	11340-117F8	83.14	50.90	1.98	34.50	4.81	1.41	5.37
Endothelial Cells - Aortic, donor3	11412-118E8	58.58	9.04	2.36	19.66	3.54	1.57	1.97
Endothelial Cells - Artery, donor1	11264-116G4	38.10	10.76	2.04	9.31	2.33	0.00	1.16
Endothelial Cells - Artery, donor2	11341-117F9	52.00	35.53	2.59	5.65	2.12	0.24	1.41
Endothelial Cells - Artery, donor3	11413-118E9	63.46	17.00	4.03	8.77	3.51	0.70	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	123.90	26.60	3.32	0.22	5.54	0.89	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	168.56	28.60	3.96	0.61	8.22	1.22	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	168.58	20.58	3.38	0.85	8.46	2.82	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	99.24	51.70	3.86	0.59	4.16	3.57	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	50.50	20.31	1.04	0.52	2.60	2.60	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	61.68	32.33	5.25	0.71	1.42	2.55	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	165.25	61.62	2.80	10.40	8.00	2.80	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	46.12	54.51	0.00	5.77	2.10	0.00	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	129.46	30.81	2.86	4.35	4.47	0.75	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	79.52	18.03	0.87	4.78	4.78	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	76.33	14.29	1.59	6.35	4.27	0.24	0.37
Endothelial Cells - Vein, donor1	11267-116G7	45.50	2.28	2.28	6.83	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	74.74	7.68	2.10	7.68	7.68	0.70	2.79
Endothelial Cells - Vein, donor3	11416-118F3	66.10	27.63	2.67	8.32	2.67	0.16	0.79
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	18.08	9.04	0.49	0.24	2.44	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	6.24	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	182.68	126.03	11.90	9.44	9.85	3.28	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	53.76	30.00	2.63	5.26	2.74	0.88	0.66
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	90.35	65.11	3.90	12.13	2.38	1.41	1.41
Fibroblast - Aortic Adventitial, donor1	11245-116E3	107.21	48.15	7.88	8.13	3.88	2.43	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	185.19	49.68	19.65	12.01	8.05	6.55	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	141.75	80.79	10.02	7.70	4.01	3.27	0.84
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	362.30	76.15	15.02	7.90	9.49	9.75	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	97.33	52.49	7.31	5.32	5.65	2.99	1.00
Fibroblast - Cardiac, donor1	11268-116G8	108.87	20.41	7.71	10.43	3.18	1.36	0.00
Fibroblast - Cardiac, donor2	11345-117G4	75.79	28.80	3.03	2.27	3.03	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	31.86	19.71	2.52	2.68	1.58	0.79	0.47
Fibroblast - Cardiac, donor4	11452-119A3	225.21	30.01	9.70	9.40	7.58	1.82	1.21
Fibroblast - Cardiac, donor5	11456-119A7	177.67	48.22	5.33	2.92	4.19	3.55	0.38
Fibroblast - Cardiac, donor6	11460-119B2	204.96	57.45	7.43	3.18	6.82	2.27	1.21
Fibroblast - Choroid Plexus, donor1	11492-119E7	306.57	74.10	7.24	4.29	10.05	4.15	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	159.63	66.44	3.88	2.59	6.47	1.29	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	49.80	51.27	1.46	1.46	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	71.04	24.68	1.85	0.23	9.23	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	192.50	44.27	14.93	11.19	7.12	4.75	0.17
Fibroblast - Dermal, donor1	11269-116G9	65.97	24.18	2.35	0.94	3.52	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	84.43	30.66	0.47	3.30	7.08	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	47.51	29.01	2.90	0.12	1.93	0.36	0.00
Fibroblast - Dermal, donor4	11450-119A1	159.28	41.15	2.37	0.11	9.95	0.68	0.00
Fibroblast - Dermal, donor5	11454-119A5	183.87	43.26	1.05	0.35	10.47	0.52	0.00
Fibroblast - Dermal, donor6	11458-119A9	217.65	62.53	3.41	0.00	11.37	0.65	0.00
Fibroblast - Gingival, donor1	11237-116D4	139.72	42.69	5.41	0.83	4.58	1.46	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	120.52	23.58	6.55	2.88	2.10	3.67	0.79
Fibroblast - Gingival, donor2	11318-117D4	155.11	81.57	5.01	0.26	6.85	0.92	0.13
Fibroblast - Gingival, donor3	11394-118C8	122.50	28.04	4.83	4.25	3.48	1.26	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	39.48	13.51	3.12	0.00	1.04	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	51.28	36.83	3.52	1.06	0.88	0.53	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	67.66	20.89	4.37	0.16	3.74	1.09	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	65.04	15.15	3.65	0.14	3.65	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	52.23	1.06	5.29	0.71	1.41	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	117.43	32.61	6.00	1.32	4.09	1.46	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	91.49	28.36	6.41	0.95	4.64	1.23	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	76.35	18.21	6.80	0.66	4.17	1.21	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	104.33	18.93	10.57	4.70	3.23	3.23	1.03
Fibroblast - Lung, donor1	11270-116H1	104.67	29.91	1.36	0.00	4.08	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	61.18	7.46	5.97	0.00	5.97	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	64.15	46.01	2.74	0.21	3.17	0.42	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	254.90	19.16	2.50	0.83	17.49	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	236.37	46.15	2.80	8.39	6.99	4.20	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	68.01	26.87	0.84	0.28	3.92	0.28	0.56
Fibroblast - Mammary, donor1	11540-120B1	117.33	8.93	6.90	0.81	13.80	2.03	0.00
Fibroblast - Mammary, donor2	11620-122A9	63.91	35.95	0.00	0.00	7.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	166.78	29.78	5.96	0.00	17.87	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	119.29	49.66	4.27	0.58	7.95	0.97	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	172.77	39.59	3.94	0.91	5.46	0.76	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	124.84	14.08	7.96	1.53	5.51	1.53	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	85.10	33.20	6.11	3.05	1.91	2.67	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	71.55	48.33	4.59	2.97	1.62	1.08	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	44.88	17.16	2.67	4.29	1.97	0.81	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	70.08	38.24	6.19	5.31	2.65	1.33	1.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	133.09	20.93	6.30	0.20	8.74	2.24	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	179.08	74.84	5.35	2.00	11.36	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	135.21	71.96	7.12	1.58	5.54	1.19	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	241.91	60.33	13.49	0.20	6.55	6.15	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	97.51	49.56	7.99	0.18	3.55	2.84	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	88.10	36.07	9.46	0.20	2.56	2.17	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	200.97	52.35	7.22	0.00	4.51	2.71	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	166.25	37.03	7.45	0.00	4.21	3.67	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	263.45	54.16	17.46	1.52	3.54	9.62	0.51
Fibroblast - skin normal, donor1	11553-120C5	85.16	37.90	9.68	0.98	4.10	6.23	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	172.64	59.35	25.46	0.00	5.21	3.21	0.00
Fibroblast - skin normal, donor2	11561-120D4	150.69	37.67	6.23	0.10	4.72	4.52	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	362.99	78.28	14.51	0.60	7.56	5.74	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	150.86	43.83	11.93	0.08	4.72	5.05	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	316.60	99.49	8.55	15.73	7.18	5.81	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	196.07	53.86	8.21	0.00	6.90	2.96	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	95.12	23.33	4.05	0.11	3.52	1.28	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	60.89	35.76	7.76	1.01	2.70	2.53	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	50.18	30.58	5.80	1.10	0.47	1.41	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	265.92	421.04	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	39.22	5.23	4.36	1.74	2.61	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	33.63	7.97	0.69	0.17	2.25	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	23.16	8.59	1.04	0.52	2.86	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	20.95	5.11	0.77	1.28	0.51	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	114.83	81.15	1.53	0.77	3.06	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	140.38	91.88	1.28	0.64	8.29	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	138.07	198.83	2.28	0.86	13.69	0.29	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	195.51	159.94	6.07	1.93	15.72	0.28	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	216.45	160.29	8.45	6.39	13.24	0.68	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	150.58	131.36	1.78	1.19	17.63	0.20	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	171.82	175.25	4.23	1.59	13.22	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	174.49	166.33	10.44	7.50	14.02	0.33	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	150.80	214.48	0.44	0.88	10.17	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	68.12	32.50	0.71	2.97	6.78	0.28	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	82.26	21.67	1.60	4.43	4.68	0.37	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	70.38	29.28	0.81	0.27	4.03	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	90.81	30.85	1.61	9.29	6.19	0.37	1.86
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	98.97	24.50	0.97	11.07	6.92	0.97	2.35
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	78.47	28.06	0.20	6.51	4.07	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	99.03	51.11	1.37	5.25	6.16	0.68	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	77.98	28.03	1.37	9.97	6.23	0.12	1.99
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	78.69	19.23	0.66	12.02	4.15	0.00	2.19
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	96.92	57.62	2.95	10.05	4.43	1.77	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	89.18	33.54	3.34	5.72	5.40	0.16	1.91
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	79.54	28.60	2.46	5.14	3.80	0.22	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	124.21	60.69	2.82	8.87	4.84	1.21	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	99.75	39.53	4.41	10.18	3.90	1.36	2.04
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	102.24	25.89	4.17	3.55	4.70	0.80	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	124.56	37.04	4.06	4.27	4.89	1.35	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	100.07	22.71	4.10	3.76	5.98	1.54	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	88.85	22.46	2.77	9.07	3.54	0.89	2.43
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	85.11	26.62	4.99	6.07	3.49	0.58	1.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	76.16	23.07	3.68	5.51	3.47	1.63	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	117.39	61.27	3.71	12.38	3.92	1.24	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	91.77	33.78	4.27	8.88	4.15	0.81	1.73
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	83.38	27.85	3.34	3.17	3.00	0.17	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	95.67	49.82	2.87	9.92	2.87	0.66	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	86.71	25.09	3.94	9.84	4.18	1.11	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	91.42	31.77	4.54	10.70	3.40	1.13	2.27
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	108.40	50.03	1.92	14.43	3.21	0.32	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	68.13	25.11	3.79	11.94	3.03	1.14	1.61
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	64.54	28.47	4.43	2.85	3.16	1.27	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	104.91	53.52	3.65	13.08	4.26	0.61	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	75.48	38.47	4.50	9.72	2.40	1.05	1.57
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	54.23	25.25	1.98	5.27	2.20	0.88	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	101.56	59.76	4.49	16.27	5.05	0.84	2.81
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	66.48	15.09	5.65	4.72	2.96	1.94	0.93
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	68.46	26.47	4.01	1.34	0.53	2.14	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	64.42	30.75	5.97	0.46	1.68	1.68	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	51.17	19.43	5.44	1.42	1.81	1.04	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	50.42	19.52	4.61	1.63	2.44	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	94.57	44.06	4.61	0.37	2.58	1.84	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	96.72	34.87	4.39	2.19	2.41	1.10	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	86.28	21.82	3.97	0.99	1.98	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	86.67	45.64	6.20	0.79	1.71	1.85	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	99.06	48.02	6.66	1.21	2.42	1.01	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	104.71	15.76	5.08	2.03	2.54	2.54	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	137.95	25.08	0.20	2.19	11.15	0.20	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	66.72	16.95	0.62	1.23	6.78	0.15	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	97.59	24.96	0.82	2.45	9.21	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	208.41	59.77	0.63	1.56	16.27	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	185.92	57.64	0.85	1.13	13.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	224.15	154.96	1.84	0.92	20.29	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	101.47	54.45	4.95	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	86.65	58.79	1.16	1.93	7.74	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	96.27	162.05	0.00	1.60	6.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	100.85	67.81	0.00	0.00	6.96	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	62.49	64.44	0.98	0.65	3.25	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	86.07	60.53	0.41	1.65	5.77	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	149.95	123.29	3.33	0.00	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	79.98	71.59	2.24	0.84	3.36	0.56	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	72.56	82.04	1.31	0.65	3.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	109.89	93.95	1.68	0.00	5.87	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	80.47	83.02	0.95	0.95	4.45	0.32	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	95.78	105.30	1.02	0.34	8.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	77.26	50.12	2.09	2.09	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	103.66	120.84	1.15	1.15	6.87	1.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	82.28	129.34	1.48	0.59	5.62	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	67.77	64.38	3.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	87.81	84.50	2.07	0.00	3.31	2.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	132.09	118.52	2.76	1.61	8.05	0.46	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	94.83	115.91	0.00	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	84.19	100.72	3.84	2.31	2.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	80.51	74.97	1.63	0.33	4.56	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	60.86	35.45	1.34	0.00	2.68	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	79.37	68.58	2.70	1.54	4.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	71.55	58.54	2.40	0.68	4.79	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	114.30	86.97	2.48	2.48	9.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	103.81	97.20	3.77	2.36	7.08	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	74.83	111.65	0.00	3.02	3.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	115.98	49.85	3.05	3.56	6.10	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	99.31	72.59	3.59	1.20	5.58	0.40	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	99.66	78.44	1.48	3.45	6.91	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	128.67	158.18	0.00	3.54	3.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	95.10	135.94	0.58	3.50	6.42	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	82.95	72.85	2.63	4.83	1.76	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	61.88	77.99	3.39	0.85	5.93	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	65.66	106.85	1.79	0.00	2.39	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	83.95	98.02	5.82	1.46	4.37	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	61.63	13.70	2.28	0.00	5.71	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	66.53	61.54	3.74	0.00	1.25	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	40.48	12.37	2.25	0.00	6.75	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	55.50	53.60	4.76	0.00	1.90	3.49	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	85.22	84.38	6.27	0.84	1.67	2.09	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	39.57	29.36	4.53	1.62	0.81	0.93	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	37.64	34.27	4.22	2.03	2.53	0.51	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	28.67	21.61	2.73	2.28	1.82	0.46	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	42.08	31.92	4.48	2.08	1.64	0.87	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	33.53	30.52	2.36	2.15	1.07	0.86	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	27.99	31.00	2.80	3.01	1.51	1.29	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	40.23	33.63	3.99	1.49	1.37	0.25	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	35.34	34.31	3.95	1.72	0.86	1.37	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	29.15	31.08	4.81	2.24	2.24	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	228.89	36.38	3.36	0.00	8.95	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	83.10	40.25	1.73	4.33	4.76	0.87	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	76.67	63.45	0.00	2.64	2.64	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	110.75	69.13	6.70	2.12	15.87	2.82	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	122.05	76.28	5.81	0.00	7.27	2.18	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	92.66	112.77	8.39	1.22	5.77	2.80	0.17
Hepatocyte, donor1	11523-119I2	24.21	9.68	2.42	0.00	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	11.85	10.77	0.00	0.00	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	42.33	33.74	2.45	0.00	0.61	1.23	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	119.44	66.57	21.54	0.00	11.75	5.22	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	41.25	12.41	3.50	0.17	0.87	0.52	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	76.01	32.38	4.25	1.51	3.84	0.82	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	0.00	0.00	0.00	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1.62	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.00	0.00	0.00	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.84	0.00	0.00	0.00	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.80	0.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.91	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1.27	1.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1.91	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.71	0.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.93	0.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.70	0.70	0.00	0.00	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	9.59	0.00	0.00	0.00	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2.13	0.00	0.00	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	1.84	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	35.58	9.71	1.39	0.57	2.12	0.16	0.16
Keratinocyte - epidermal, donor2	11349-117G8	11.13	3.51	0.59	0.00	1.76	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	18.84	5.21	0.38	0.00	1.23	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	34.17	12.26	1.02	0.00	2.61	0.00	0.00
Keratocytes, donor1	11527-119I6	59.48	30.60	4.47	1.03	6.53	0.69	0.34
Keratocytes, donor2	11607-120I5	110.15	62.11	2.34	0.00	9.37	0.00	0.00
Keratocytes, donor3	11688-122I5	155.71	48.21	4.15	3.16	5.14	1.19	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	274.74	54.95	0.00	6.59	19.78	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	33.44	66.88	1.08	0.00	3.24	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	92.61	36.44	9.80	2.42	7.15	1.61	0.35
Lens Epithelial Cells, donor3	11690-122I7	62.36	15.24	7.87	2.42	3.43	1.41	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	178.46	55.14	14.82	1.30	6.17	6.76	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	106.89	112.47	5.58	0.28	4.19	2.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	158.04	116.48	10.39	0.79	4.72	7.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	101.09	131.20	5.91	1.08	4.30	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	148.76	93.60	6.30	0.32	2.52	3.15	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	118.70	96.93	7.12	0.86	2.05	3.88	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	87.82	104.24	5.34	0.41	4.10	1.23	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	99.11	100.12	7.33	0.51	3.03	2.53	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	126.68	99.37	8.73	1.69	4.08	3.94	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	81.48	83.85	4.75	1.98	2.37	1.98	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	119.04	112.84	8.72	0.58	3.10	5.04	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	77.76	64.80	5.18	1.11	2.22	2.78	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	94.77	125.08	6.97	1.05	3.83	3.83	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	115.92	94.69	7.87	0.24	4.29	2.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	120.04	109.74	7.28	0.82	2.61	5.49	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	81.92	100.39	4.31	1.85	3.70	1.54	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	95.39	86.66	4.68	0.00	3.43	3.12	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	130.84	94.42	8.60	1.28	2.56	4.03	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	76.68	112.88	3.95	1.65	1.97	2.30	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	111.00	87.86	4.10	0.29	4.69	3.81	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	113.26	105.55	6.72	1.49	1.99	4.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	80.99	96.99	5.82	0.00	4.36	3.88	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	104.49	97.22	6.46	0.00	2.42	5.92	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	137.30	103.69	6.51	1.36	4.54	4.24	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	88.13	102.13	3.63	1.04	5.70	2.07	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	98.62	96.74	7.54	0.21	3.35	3.35	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	124.36	90.37	8.42	1.05	4.36	4.51	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	74.29	109.37	4.13	0.69	5.50	4.82	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	100.10	76.58	7.34	0.38	3.76	2.26	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	100.83	83.87	6.36	1.06	1.59	4.77	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	73.66	104.67	2.42	0.48	1.94	2.91	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	84.02	87.99	3.64	0.33	1.65	2.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	120.42	96.51	7.31	0.99	3.10	3.35	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	108.84	111.06	7.77	0.37	5.92	2.59	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	80.30	93.40	5.93	0.74	2.47	2.47	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	107.11	84.56	7.15	0.82	3.71	3.44	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	84.27	105.50	4.50	0.32	3.54	2.25	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	108.04	96.47	4.87	0.61	4.56	2.43	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	128.63	98.54	8.40	1.26	5.04	3.78	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	89.25	114.14	4.62	1.07	3.56	3.56	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	70.29	88.71	4.36	0.97	3.39	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	103.17	78.74	5.76	0.62	2.33	2.96	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	82.72	92.75	4.30	0.72	4.30	3.94	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	96.37	59.45	3.27	0.33	3.59	1.31	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	89.46	91.11	5.65	0.47	2.12	4.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	137.49	43.44	12.00	0.74	4.21	5.45	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	68.13	60.19	3.84	0.26	2.31	1.79	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	89.81	82.64	7.76	1.19	2.09	5.37	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	0.00	0.00	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	14.58	12.27	0.00	0.00	3.07	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	11.13	2.97	0.00	1.48	4.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	23.27	10.16	0.00	2.12	3.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	14.07	8.44	0.00	0.70	2.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	18.68	1.87	0.00	0.93	3.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	17.52	14.94	0.52	0.00	2.06	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	19.03	7.14	0.00	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	16.74	1.36	0.45	1.58	2.94	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	20.36	15.70	0.00	1.16	2.04	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	19.36	11.25	0.90	1.80	4.05	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	21.54	2.30	0.14	0.95	2.85	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.00	11.30	0.00	1.54	3.59	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	15.88	11.29	0.35	0.71	3.88	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	14.66	6.66	0.00	3.33	2.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	22.41	8.15	0.51	2.04	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	19.74	8.54	0.00	2.13	2.67	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	24.94	16.63	0.19	1.32	3.21	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	17.79	11.66	0.00	2.45	1.84	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	20.39	7.34	0.82	2.45	3.26	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	20.62	14.58	0.21	2.08	3.12	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	23.82	16.54	0.28	1.68	3.36	0.28	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	24.73	5.15	1.03	2.06	4.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	21.19	14.52	0.29	0.58	2.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	17.34	16.14	0.60	1.79	3.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	13.83	13.28	0.55	3.32	2.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	26.51	10.60	0.00	2.12	2.12	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	20.65	11.80	0.37	1.84	2.95	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	5.76	0.00	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	21.11	9.59	0.77	1.54	3.07	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	24.91	9.62	0.57	2.26	1.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	22.97	3.28	0.00	0.82	4.10	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	22.14	9.04	0.45	1.36	3.16	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.05	12.93	0.72	1.44	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	17.18	9.71	0.75	3.73	2.24	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	18.95	8.55	0.00	1.49	1.11	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	20.68	14.21	0.43	2.15	3.45	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	15.41	3.43	0.86	3.43	2.57	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	20.99	10.33	1.00	1.67	3.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.89	9.65	0.00	1.21	0.60	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	26.31	2.84	0.00	2.13	1.42	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	23.03	10.66	0.34	0.69	2.06	0.34	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	14.49	11.27	0.00	2.68	2.15	0.00	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	11.45	3.37	0.00	2.69	2.02	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	22.22	9.63	0.00	1.48	4.07	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	5.81	1.16	0.00	2.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	13.75	8.46	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	27.21	8.80	0.00	4.40	2.00	0.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	16.72	8.00	0.00	0.73	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	22.23	5.37	1.53	0.00	2.30	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	21.21	9.37	0.49	2.96	2.47	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	6.59	0.00	0.00	3.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	17.60	5.03	0.00	2.51	2.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	31.09	8.11	0.00	0.90	4.06	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	12.05	0.00	0.00	3.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	17.81	9.35	0.89	1.78	2.67	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	25.03	12.12	0.00	0.78	3.13	0.00	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	15.17	6.60	0.00	0.66	3.96	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	16.61	6.75	2.08	0.00	2.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	16.19	6.13	0.00	1.75	1.75	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	17.33	7.83	0.00	0.56	5.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	13.25	7.51	0.00	1.32	1.77	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	26.61	8.10	0.00	1.16	1.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.23	10.63	0.00	2.53	1.01	0.00	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	13.46	6.73	0.00	1.44	1.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	25.05	11.53	0.00	2.39	2.78	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	16.41	12.15	1.22	0.61	1.82	0.00	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	17.29	7.61	0.00	2.08	4.84	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	17.86	6.84	0.00	2.66	2.28	0.00	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	18.59	12.91	0.00	2.07	2.58	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	12.70	2.42	0.00	1.81	1.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	23.77	7.61	0.00	2.54	3.17	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	16.53	9.06	0.00	1.60	1.07	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	29.88	3.45	0.00	1.72	2.30	0.00	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	28.80	7.71	0.00	1.54	1.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	19.10	7.78	0.00	1.41	3.54	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	24.97	7.94	0.00	1.70	1.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	31.62	6.24	0.42	0.83	3.33	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	25.06	5.48	0.00	1.57	2.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	19.21	5.01	0.00	1.67	3.34	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	14.40	6.50	0.00	1.39	5.11	0.00	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.75	10.04	0.00	2.01	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	27.80	3.74	0.00	1.60	3.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	17.38	3.23	0.40	2.42	2.83	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.93	7.34	0.00	3.67	0.92	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	25.78	2.67	0.00	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	21.09	3.42	0.00	0.57	4.56	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	18.41	5.37	0.00	3.83	1.53	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	20.25	3.28	0.00	1.64	2.19	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	15.15	3.12	0.00	4.01	4.90	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	15.86	1.56	0.00	3.38	2.86	0.00	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	25.20	5.97	0.00	1.33	1.33	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	24.94	6.24	0.00	2.08	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	126.95	33.73	6.84	0.00	7.07	1.60	0.00
Macrophage - monocyte derived, donor2	11313-117C8	117.81	23.86	3.85	0.00	10.83	1.28	0.00
Macrophage - monocyte derived, donor3	11389-118C3	78.12	27.40	6.16	0.00	6.69	2.36	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	8.50	1.59	1.59	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	17.27	4.12	1.27	0.63	1.27	0.00	0.32
Mallassez-derived cells, donor3	11930-125I4	17.93	5.84	0.69	0.14	0.97	0.28	0.00
Mammary Epithelial Cell, donor1	11273-116H4	47.53	42.05	3.99	5.88	3.49	1.59	0.90
Mammary Epithelial Cell, donor2	11350-117G9	32.72	25.48	2.03	2.03	4.05	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	50.63	12.22	2.99	2.74	2.74	1.00	1.75
Mast cell - stimulated, donor1	11487-119E2	22.37	0.68	1.36	0.00	3.39	0.00	0.00
Mast cell, donor1	11563-120D6	37.85	11.35	3.68	0.11	3.14	0.76	0.11
Mast cell, donor2	11565-120D8	231.80	55.57	53.49	0.30	13.67	11.59	0.00
Mast cell, donor3	11566-120D9	172.00	41.87	26.11	0.23	10.81	3.83	0.00
Mast cell, donor4	11567-120E1	269.48	75.17	41.84	0.18	17.02	7.80	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	44.69	5.21	2.55	0.00	3.99	1.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	35.02	14.01	1.75	0.00	4.09	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	43.36	8.15	2.87	0.00	5.16	0.11	0.11
Mast cell, expanded, donor8	11941-126A6	47.20	11.21	4.02	0.00	3.51	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	57.91	22.09	3.68	1.29	2.49	0.30	0.00
Melanocyte - dark, donor2	11582-120F7	86.52	66.79	1.73	2.77	4.85	1.73	0.35
Melanocyte - dark, donor3	11663-122F7	37.89	22.82	6.88	0.00	2.61	1.38	0.00
Melanocyte - light, donor1	11274-116H5	23.74	4.94	3.06	0.24	0.94	1.18	0.00
Melanocyte - light, donor2	11351-117H1	22.52	2.05	4.78	0.00	2.05	2.05	0.00
Melanocyte - light, donor3	11423-118G1	26.02	14.74	3.47	0.87	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	40.50	20.93	4.79	0.10	1.87	2.60	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	56.48	45.45	4.30	0.27	1.34	1.88	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	34.82	21.70	1.34	0.54	3.21	1.07	0.00
Meningeal Cells, donor1	11493-119E8	258.79	45.53	8.06	3.60	15.63	3.47	0.87
Meningeal Cells, donor2	11573-120E7	194.11	39.61	6.16	3.08	8.36	1.32	1.76
Meningeal Cells, donor3	11654-122E7	157.05	51.43	7.50	1.55	7.91	3.75	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	58.46	31.37	5.13	0.29	3.14	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	50.01	20.23	3.82	0.40	2.72	1.61	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	28.91	3.94	1.31	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	43.17	23.55	3.92	0.00	2.62	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	45.21	25.12	2.15	0.00	2.15	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	67.34	35.79	7.62	0.21	2.75	1.91	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	74.89	67.35	5.03	0.00	4.02	1.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	65.71	33.62	4.18	0.66	7.03	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	54.79	47.49	2.92	0.00	5.11	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	68.75	28.64	2.86	1.23	6.55	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	67.59	25.21	2.22	8.59	5.26	0.97	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	90.33	44.98	5.95	0.37	7.43	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	281.96	97.10	9.47	2.50	8.68	3.29	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	50.74	31.45	6.23	0.30	2.37	1.78	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	46.71	32.70	2.34	2.34	4.67	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	120.40	28.18	7.04	1.92	6.40	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	42.89	32.61	4.25	0.00	1.42	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	181.38	83.81	7.19	3.44	5.94	1.25	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	47.90	49.35	3.63	0.00	2.18	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	37.65	31.56	6.36	6.89	2.92	0.80	1.06
Mesothelial Cells, donor2	12156-128G5	23.52	7.01	2.50	4.50	2.00	0.00	1.00
Mesothelial Cells, donor3	11402-118D7	31.36	16.77	2.60	5.28	1.45	1.16	1.01
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	133.68	18.90	0.00	0.00	6.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	143.09	42.11	2.46	0.49	6.65	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	71.26	12.37	1.47	0.00	4.12	1.47	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	62.23	6.91	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	113.75	41.84	3.72	0.62	6.82	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	56.84	19.08	1.87	0.21	7.05	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	46.32	11.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	99.10	35.54	2.25	0.00	7.26	0.75	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	67.49	13.03	2.33	0.47	6.05	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	94.50	32.72	2.03	0.81	5.69	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	62.96	19.40	1.58	0.00	3.17	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	25.65	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	89.38	38.05	1.77	0.88	7.96	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	55.09	32.67	0.76	0.00	4.18	1.14	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	30.27	0.00	0.00	0.00	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	99.96	39.69	1.91	0.21	6.37	0.42	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	43.28	2.76	0.92	0.00	7.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	91.80	28.02	3.58	0.00	6.86	0.89	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	36.89	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	86.81	44.41	2.26	0.25	5.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	62.98	14.74	1.43	0.00	2.38	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	54.18	2.76	0.55	0.00	2.76	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	66.31	42.83	3.68	0.00	5.53	1.61	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	58.68	13.46	1.68	0.00	5.89	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	107.62	14.27	1.83	0.41	6.93	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	85.39	49.77	3.65	0.21	5.15	0.86	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	69.58	12.23	1.78	0.00	5.78	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	99.43	42.71	2.63	0.22	7.23	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	67.43	6.59	0.51	0.51	5.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	74.56	9.94	0.00	0.00	4.97	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	133.45	38.32	1.36	0.82	9.78	0.82	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	95.28	17.06	0.59	0.00	9.41	0.88	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	97.04	16.35	0.00	0.00	6.54	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	119.66	74.49	2.40	0.00	4.81	1.44	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	112.86	30.82	1.20	0.00	8.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	120.67	47.99	4.11	0.00	8.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	124.14	80.59	6.01	0.50	11.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	296.42	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	97.85	10.19	0.00	2.04	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	159.84	109.48	5.69	1.75	13.58	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	76.15	18.76	0.00	0.00	8.83	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	105.66	11.53	1.28	1.28	3.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	184.95	128.17	2.23	0.25	12.15	2.73	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	104.38	13.92	0.00	0.00	10.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	95.02	17.68	2.21	0.00	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	170.25	129.57	4.10	2.74	11.62	1.71	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	123.41	14.88	0.00	1.31	7.44	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	130.68	23.08	1.07	1.07	9.23	1.42	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	202.28	123.72	1.96	1.68	13.75	1.96	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	133.83	13.72	1.25	0.00	12.05	1.66	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	115.97	13.99	2.33	1.75	5.24	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	165.01	88.99	1.21	1.51	9.65	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	194.50	42.57	2.50	0.00	16.70	1.67	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	79.41	14.44	0.00	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	180.09	59.11	0.92	0.00	12.01	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	196.35	35.85	2.28	0.57	18.78	1.71	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	139.84	14.37	2.07	1.11	9.26	0.83	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	152.64	104.44	3.37	2.59	10.11	0.52	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	173.31	18.45	1.72	0.43	13.73	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	65.42	5.72	0.00	0.00	3.81	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	146.79	31.49	2.14	0.80	13.08	0.00	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	128.41	29.93	2.39	1.50	12.87	1.20	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	77.41	8.19	0.85	0.71	5.23	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	145.88	102.88	1.91	2.23	10.83	0.32	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	147.94	28.97	0.88	0.44	12.38	0.88	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	102.38	7.96	2.28	0.38	8.34	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	129.84	74.44	0.85	1.42	13.64	0.57	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	174.52	42.28	2.46	0.49	15.73	0.74	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	65.17	16.94	0.65	0.00	1.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	107.32	43.81	2.06	0.29	8.23	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	124.56	22.78	2.31	0.29	10.96	1.15	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	140.95	35.86	3.30	0.00	9.89	1.24	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	78.61	20.25	1.19	0.00	4.47	0.89	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	75.34	195.88	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	60.60	83.77	3.56	0.00	0.00	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	122.89	62.76	2.30	0.00	4.27	1.97	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	76.79	134.65	2.10	0.00	5.26	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	173.17	59.70	3.16	0.79	9.29	1.19	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	171.36	84.75	4.66	3.73	12.11	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	125.80	81.11	4.51	0.75	11.27	2.63	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	87.63	82.30	2.13	0.27	6.92	1.33	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	63.34	19.91	2.83	0.23	1.24	0.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	104.61	82.51	0.74	0.74	2.95	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	113.96	60.83	1.83	0.00	2.93	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	93.34	138.45	3.11	0.00	10.89	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	21.38	8.02	1.07	0.53	1.07	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	38.64	88.87	3.86	0.00	15.46	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	97.96	59.59	3.03	0.00	5.05	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	66.20	32.89	0.84	0.00	3.79	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	1.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.72	1.91	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	0.00	0.81	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	31.72	15.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	5.71	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	6.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	79.28	52.14	6.25	13.79	3.45	2.59	1.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	123.86	102.95	6.27	10.97	3.66	2.09	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	167.54	17.35	4.67	0.00	4.67	2.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	57.60	18.78	2.92	0.00	2.50	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	116.56	34.23	8.56	0.00	2.09	0.57	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	215.44	23.94	3.19	0.00	6.38	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	104.71	22.44	0.68	0.00	6.80	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	95.56	198.47	7.35	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	104.22	19.25	2.51	0.00	5.02	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	77.17	28.13	7.90	0.00	3.95	0.70	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	133.49	12.16	4.59	0.27	6.22	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	114.79	43.73	3.99	0.00	3.99	0.84	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	233.83	523.33	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	145.43	26.31	6.45	0.00	4.96	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	64.69	41.68	5.41	0.27	0.27	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	89.77	23.80	6.35	0.68	3.85	1.59	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	72.67	12.57	5.23	0.16	4.08	0.49	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	131.41	44.11	4.19	0.55	2.92	1.28	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	139.50	30.23	3.18	0.00	4.77	3.18	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	156.08	25.81	4.20	0.00	8.40	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	89.59	38.72	9.52	0.33	0.98	1.64	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	70.42	16.91	6.50	0.16	3.09	0.81	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	136.34	27.69	4.76	0.00	2.82	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	107.59	25.32	3.52	0.00	5.63	2.11	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	118.15	50.57	11.49	0.00	1.84	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	108.94	22.82	4.82	0.32	5.78	1.29	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	112.43	83.81	12.76	0.34	2.76	1.72	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	156.76	68.27	20.23	0.00	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	113.40	23.39	4.01	0.22	2.23	1.56	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	81.29	36.84	5.93	0.00	2.54	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	122.95	50.08	11.87	0.00	2.61	1.90	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	104.31	19.75	3.00	0.00	4.29	2.58	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	505.55	532.64	36.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	125.62	16.99	4.00	0.67	6.00	1.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	86.57	18.49	2.71	0.00	4.06	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	78.57	22.22	3.17	0.00	2.38	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	272.09	48.29	13.00	0.00	7.43	3.71	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	71.13	27.62	6.05	0.38	0.38	1.14	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	102.00	21.83	3.26	0.00	2.93	1.30	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	131.17	12.20	3.05	1.31	5.67	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	77.79	24.42	1.81	0.90	3.62	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	134.93	37.92	7.06	0.00	2.65	2.65	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	201.45	48.53	7.31	0.00	7.98	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	143.85	19.35	1.98	0.00	6.45	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	107.19	22.20	5.36	0.00	4.98	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	67.45	52.63	5.75	0.30	2.72	1.21	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	71.39	28.07	3.98	0.00	1.77	1.33	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	111.14	29.82	2.71	0.00	6.10	2.71	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	224.82	434.31	5.11	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	128.64	18.29	1.83	0.00	3.66	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	67.67	29.27	5.04	0.00	0.94	1.89	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	108.05	27.24	5.75	1.21	3.33	0.61	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	122.63	41.93	3.96	0.00	6.33	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	97.49	116.77	7.94	0.00	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	156.79	434.98	10.12	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	42.61	15.40	3.48	1.61	1.86	1.37	0.12
Myoblast, donor2	11322-117D8	63.48	46.03	4.03	0.19	2.49	1.53	0.19
Myoblast, donor3	11398-118D3	38.34	10.76	4.88	0.17	2.35	0.34	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	67.57	38.23	5.84	0.00	3.65	0.88	0.00
Natural Killer Cells, donor1	11230-116C6	20.91	7.07	1.85	0.00	1.23	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	15.68	9.05	0.30	0.00	0.60	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	22.64	11.96	0.74	0.00	0.74	0.18	0.00
Neural stem cells, donor1	11275-116H6	343.34	39.20	23.95	22.50	8.71	10.89	6.53
Neural stem cells, donor2	11352-117H2	492.96	75.10	48.14	59.69	23.11	13.48	17.33
Neurons, donor1	11494-119E9	312.92	187.75	31.86	46.65	10.24	11.38	7.97
Neurons, donor2	11574-120E8	332.89	154.33	53.72	74.64	14.53	10.35	24.66
Neurons, donor3	11655-122E8	448.08	294.34	50.15	37.82	9.04	14.80	11.51
Neutrophils, donor1	11233-116C9	0.93	0.93	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	2.44	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	63.52	22.68	5.70	1.66	2.37	1.42	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	45.91	37.44	2.93	0.65	3.26	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	71.40	50.14	2.41	2.41	2.21	1.20	0.60
Olfactory epithelial cells, donor1	11933-125I7	210.88	158.85	12.25	7.43	5.64	3.99	0.28
Olfactory epithelial cells, donor2	11934-125I8	243.17	166.89	13.32	9.55	5.93	4.34	2.03
Olfactory epithelial cells, donor3	11935-125I9	201.13	144.38	10.67	4.31	4.31	5.22	0.57
Olfactory epithelial cells, donor4	11936-126A1	356.57	134.31	12.66	38.08	8.08	3.41	3.41
Oligodendrocyte - precursors, donor1	11496-119F2	114.35	41.53	8.43	5.42	5.42	1.20	1.20
Osteoblast - differentiated, donor1	11276-116H7	139.95	27.65	7.23	13.83	4.47	4.68	0.85
Osteoblast - differentiated, donor2	11353-117H3	83.45	35.44	2.29	1.14	2.29	2.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	60.83	21.72	1.86	12.41	1.24	0.00	1.86
Osteoblast, donor1	11277-116H8	91.46	29.12	8.21	0.39	7.62	1.76	0.00
Osteoblast, donor2	11354-117H4	68.12	32.31	6.32	1.40	6.32	0.00	0.00
Osteoblast, donor3	11426-118G4	43.72	10.49	2.67	1.96	2.31	0.53	0.18
Pancreatic stromal cells, donor1	11249-116E7	100.49	38.66	9.18	0.17	2.61	1.26	0.00
Pericytes, donor1	11491-119E6	96.02	21.14	2.34	0.45	7.23	0.00	0.00
Pericytes, donor2	11571-120E5	105.03	32.14	2.26	1.13	3.17	0.45	0.23
Pericytes, donor3	11652-122E5	199.58	94.40	6.10	6.92	11.39	1.22	0.41
Perineurial Cells, donor1	11499-119F5	166.25	90.08	7.80	21.13	6.56	1.36	4.07
Perineurial Cells, donor2	11579-120F4	101.95	23.37	4.88	5.34	4.23	1.29	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	64.07	16.57	1.27	0.32	3.19	2.23	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	66.60	30.85	1.47	0.00	3.67	1.96	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	51.64	11.39	1.81	0.00	2.33	0.91	0.00
Placental Epithelial Cells, donor1	11278-116H9	41.38	18.42	3.35	0.00	1.91	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	53.23	39.92	4.44	0.00	3.33	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	88.35	34.75	2.94	0.20	3.73	0.79	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	54.11	25.63	2.22	1.58	2.22	3.48	0.00
Preadipocyte - breast, donor1	11467-119B9	139.38	93.61	8.44	2.81	5.63	7.13	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	219.81	96.20	34.07	2.61	5.61	10.96	0.52
Preadipocyte - breast, donor2	11328-117E5	122.03	100.42	11.03	3.60	2.03	6.08	0.23
Preadipocyte - omental, donor1	11468-119C1	235.17	92.60	14.07	9.59	8.21	8.42	0.85
Preadipocyte - omental, donor2	11329-117E6	122.21	53.69	15.71	2.62	3.49	6.98	0.44
Preadipocyte - omental, donor3	11403-118D8	91.68	75.49	11.46	8.59	5.30	3.44	0.43
Preadipocyte - perirenal, donor1	11469-119C2	140.75	76.77	11.81	13.78	1.97	6.89	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	58.66	5.53	4.30	0.31	7.06	1.84	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	91.37	54.89	3.72	0.18	6.37	0.71	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	60.96	37.63	3.24	0.34	2.04	0.51	0.00
Preadipocyte - visceral, donor1	11280-116I2	92.59	36.23	6.05	0.19	5.22	1.02	0.00
Preadipocyte - visceral, donor2	11357-117H7	125.63	51.08	5.06	0.92	2.76	2.30	0.00
Preadipocyte - visceral, donor3	11429-118G7	82.13	51.83	2.40	0.10	3.55	0.73	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	30.47	11.31	3.62	0.45	1.66	1.36	0.15
Prostate Epithelial Cells, donor2	11331-117E8	13.81	7.31	0.95	0.68	0.54	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	3.74	1.41	0.06	0.18	0.24	0.06	0.00
Prostate Stromal Cells, donor1	11254-116F3	84.63	41.80	9.57	2.96	3.87	2.96	0.23
Prostate Stromal Cells, donor2	11332-117E9	64.73	63.11	7.89	1.61	3.77	1.08	0.00
Prostate Stromal Cells, donor3	11405-118E1	57.98	46.51	8.97	2.09	1.36	2.40	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	35.04	16.42	1.46	10.22	4.74	0.00	2.55
Renal Cortical Epithelial Cells, donor2	11596-120H3	48.86	34.59	0.76	21.28	2.50	0.21	2.43
Renal Epithelial Cells, donor1	11517-119H5	32.97	12.68	2.54	6.09	5.58	0.51	3.04
Renal Epithelial Cells, donor2	11597-120H4	46.95	49.08	0.00	5.69	2.85	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	46.69	23.71	1.06	18.00	1.91	0.00	3.18
Renal Glomerular Endothelial Cells, donor1	11514-119H2	128.00	56.51	1.36	0.68	8.17	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	154.04	59.84	0.94	1.62	5.39	0.27	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	69.93	33.30	3.11	2.22	4.44	0.89	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	81.85	13.97	2.66	0.00	2.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	52.60	34.77	3.30	7.04	3.96	0.00	1.54
Renal Mesangial Cells, donor2	11598-120H5	62.07	42.63	4.39	4.39	2.51	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	39.67	21.64	2.22	6.94	3.88	0.55	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	31.94	28.45	2.15	9.93	4.03	0.54	4.03
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	35.84	25.30	1.27	5.90	4.64	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	56.70	29.31	1.35	5.40	5.59	0.39	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	52.89	33.97	1.81	0.52	4.41	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	63.67	27.86	2.84	1.14	4.55	1.42	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	52.49	30.87	1.03	0.00	2.06	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	26.85	10.79	0.50	2.51	3.51	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	157.82	50.92	6.28	2.00	4.28	1.47	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	54.50	11.61	6.25	7.15	0.89	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	73.20	16.51	3.85	3.85	2.75	1.65	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	41.18	3.48	3.48	2.32	4.06	1.16	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	69.17	10.40	0.78	0.26	1.82	0.78	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	73.39	16.09	2.09	0.10	2.58	0.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	70.05	13.83	4.02	0.22	3.12	0.56	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	85.09	14.89	3.35	0.25	1.12	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	73.42	20.75	2.33	0.93	2.21	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	108.63	24.73	3.70	0.92	4.16	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	69.96	10.95	0.68	0.55	2.33	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	66.56	12.86	1.82	0.61	1.66	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	58.24	9.32	1.61	0.72	4.84	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	71.01	13.20	1.58	0.43	2.73	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	69.11	18.03	3.22	0.21	3.22	0.75	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	76.12	22.35	2.43	0.00	4.65	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	72.07	10.13	1.34	0.38	1.15	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	66.43	13.97	2.89	0.47	2.05	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	73.28	13.34	3.01	0.38	3.76	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	77.50	7.96	1.06	0.00	2.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	49.94	10.42	2.73	0.58	2.34	0.58	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	81.35	17.19	2.29	0.38	2.86	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	66.43	7.37	2.03	0.32	1.71	0.32	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	77.08	19.06	1.12	0.00	3.92	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	70.75	14.36	2.22	0.34	2.91	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	74.76	8.57	1.28	0.00	2.55	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	66.83	13.98	2.70	0.37	1.96	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	61.12	18.94	1.34	0.27	1.75	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	68.64	17.45	1.42	0.71	2.59	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	74.01	15.87	1.98	0.40	3.97	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	88.39	20.34	2.57	0.70	2.34	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	68.43	12.23	0.83	0.00	2.90	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	78.75	17.70	1.99	0.22	1.99	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	81.05	19.01	3.34	0.42	2.51	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	61.77	10.23	1.48	0.54	2.69	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	70.50	9.20	2.04	0.00	2.04	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	88.11	15.81	1.93	0.58	3.86	0.77	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	56.40	10.83	1.20	0.34	2.41	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	56.51	8.64	2.33	0.27	1.78	0.82	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	69.77	14.28	2.63	0.33	2.96	0.33	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	91.01	10.74	2.22	0.17	4.77	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	55.19	17.75	3.85	0.15	2.52	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	89.03	15.19	1.87	0.53	1.87	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	107.43	15.49	1.24	1.66	3.46	0.55	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	92.15	41.67	3.81	0.24	3.10	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	138.86	14.71	4.43	1.21	5.04	1.01	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	89.09	17.42	2.17	0.85	2.83	0.66	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	82.80	19.56	2.79	0.70	1.75	1.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	69.81	16.02	3.63	0.30	3.63	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	73.06	13.83	2.33	0.49	2.33	1.10	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	82.67	11.06	5.09	2.18	4.22	1.31	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	68.14	21.90	2.43	2.43	2.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	70.23	13.56	2.71	1.21	2.11	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	62.88	21.94	3.17	3.85	2.94	0.90	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	52.72	14.68	4.79	3.29	2.10	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	62.82	14.52	3.07	2.83	2.24	1.53	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	56.56	11.31	2.56	3.63	1.92	0.64	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	64.30	7.21	2.40	3.61	2.40	1.20	0.00
Schwann Cells, donor1	11498-119F4	70.34	34.61	3.01	0.94	4.70	0.38	0.19
Schwann Cells, donor2	11578-120F3	47.63	44.23	0.00	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	73.39	103.19	7.67	0.66	3.72	1.97	0.00
Sebocyte, donor1	11220-116B5	35.61	5.48	1.64	0.00	3.83	0.55	0.00
Sebocyte, donor2	11301-117B5	35.39	11.03	0.46	0.00	1.84	0.46	0.00
Sebocyte, donor3	11378-118B1	51.32	16.70	2.27	0.41	1.24	1.44	0.00
Sertoli Cells, donor1	11255-116F4	117.62	115.96	11.60	19.88	8.28	1.66	1.66
Sertoli Cells, donor2	11333-117F1	305.03	302.21	8.47	42.37	2.82	0.00	8.47
Skeletal Muscle Cells, donor1	11281-116I3	70.03	32.20	5.45	0.09	3.26	0.70	0.09
Skeletal Muscle Cells, donor2	11358-117H8	26.75	5.06	1.45	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	125.41	32.61	3.34	0.00	11.70	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	142.01	66.14	1.41	0.79	7.38	0.31	0.16
Skeletal Muscle Cells, donor5	11455-119A6	160.98	61.24	1.49	1.04	6.99	0.45	0.15
Skeletal Muscle Cells, donor6	11459-119B1	99.88	43.71	2.00	0.15	6.46	0.62	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	160.66	45.87	6.05	0.25	8.19	1.39	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	135.13	58.22	3.28	0.14	5.85	0.71	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	100.80	32.44	2.88	0.40	5.56	0.10	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	61.59	33.20	6.15	0.51	2.44	2.02	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	40.53	15.92	2.90	0.00	2.17	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	96.18	29.17	3.30	0.00	3.16	0.83	0.00
Skin - palm, donor1	10286-104F7	147.74	13.43	5.37	0.00	2.69	13.43	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	11.10	3.46	0.58	0.29	0.43	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	26.17	7.36	0.00	0.00	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	18.05	3.25	0.39	0.00	1.30	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	11.12	4.87	0.28	0.56	0.56	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	17.02	6.33	0.56	0.42	0.84	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	21.99	4.23	1.90	0.00	0.85	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	11.39	3.82	0.15	0.60	0.97	0.07	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	90.42	46.29	0.93	5.25	3.39	0.62	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	281.25	46.24	8.00	6.45	10.67	2.45	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	50.55	17.63	2.94	0.00	4.70	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	123.09	27.40	6.85	2.21	5.30	1.33	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	74.42	21.26	5.12	9.84	4.73	0.79	2.76
Smooth Muscle Cells - Aortic, donor3	11432-118H1	84.98	13.91	3.86	1.55	2.32	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	104.08	107.08	5.00	0.00	2.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	150.51	33.67	7.59	15.57	10.51	2.66	2.66
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	173.56	129.45	5.98	7.98	7.31	1.11	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	123.93	17.16	2.43	8.96	2.94	0.90	1.66
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	110.05	49.82	9.44	0.98	7.81	2.93	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	113.70	30.12	6.79	0.89	5.61	2.07	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	67.77	18.93	3.27	2.14	2.99	0.57	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	52.54	23.26	2.44	0.16	5.69	0.81	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	98.64	45.06	6.70	3.35	5.78	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	234.88	24.50	10.36	10.86	11.11	3.28	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	116.29	24.48	0.00	18.36	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	112.06	28.13	3.81	8.11	8.58	0.95	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	81.85	33.48	3.39	0.29	3.83	1.92	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	136.89	61.34	3.44	0.86	7.10	1.29	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	98.24	33.80	4.20	0.31	6.51	0.73	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	91.72	28.62	4.80	13.92	7.27	1.70	2.63
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	49.58	20.48	2.16	6.47	1.08	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	82.19	27.49	4.78	5.08	4.48	1.20	2.09
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	83.64	37.21	2.39	0.00	9.90	2.39	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	199.94	80.96	7.54	0.24	5.58	1.96	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	148.04	58.07	2.21	38.65	6.04	0.40	4.73
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	78.96	84.42	4.32	2.73	1.37	1.82	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	83.33	28.38	0.00	0.60	3.62	3.62	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	65.44	16.16	3.18	0.00	6.09	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	96.27	54.33	5.59	0.80	5.33	2.26	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	164.16	97.67	9.02	1.88	5.01	3.26	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	74.58	30.44	8.37	2.28	2.03	2.03	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	113.68	38.60	11.76	5.58	6.18	1.81	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	150.78	50.26	4.50	3.00	6.00	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	536.27	96.92	1.29	16.80	6.46	1.29	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	153.94	16.28	8.37	0.47	10.70	1.86	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	130.76	87.85	7.07	13.13	3.03	2.02	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	172.99	52.96	2.82	10.97	8.78	1.88	3.13
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	63.72	30.68	3.24	0.88	6.49	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	62.56	26.16	4.83	0.00	4.08	0.83	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	158.37	71.01	5.61	0.93	6.07	1.87	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	46.34	8.35	2.45	2.01	2.59	0.58	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	47.93	17.08	2.80	0.76	4.08	1.27	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	84.05	26.14	3.20	0.19	2.26	1.50	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	85.38	35.91	5.45	1.26	6.15	0.98	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	71.89	38.88	9.13	1.42	3.77	2.18	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	17.62	10.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	32.05	8.56	4.16	1.47	1.22	0.73	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	73.13	39.77	3.54	0.44	3.31	1.33	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	76.95	17.85	2.05	0.00	1.46	0.59	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	81.05	40.62	4.08	0.97	2.14	1.36	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	55.27	34.38	2.91	2.38	2.91	1.06	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	68.07	50.58	3.35	1.12	2.60	1.86	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	68.27	40.25	2.52	1.80	3.95	0.72	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	24.70	8.23	0.28	0.00	1.42	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	64.99	50.02	5.51	0.00	5.12	2.76	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	69.07	46.22	2.54	3.81	3.30	0.51	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	69.08	34.74	1.60	2.00	2.80	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	67.30	107.85	3.76	4.60	2.51	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	103.59	116.42	5.96	2.75	2.29	1.83	0.00
Synoviocyte, donor1	11291-117A4	94.60	53.53	4.88	26.26	2.36	1.18	3.70
Synoviocyte, donor2	11368-117I9	105.10	116.67	10.56	14.25	2.01	5.03	0.84
Synoviocyte, donor3	11440-118H9	156.61	123.99	7.60	21.45	2.90	2.68	1.34
Trabecular Meshwork Cells, donor1	11532-120A2	135.07	47.53	5.72	0.36	12.51	1.07	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	47.57	19.82	1.98	1.98	5.95	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	135.22	38.90	3.70	0.00	7.41	1.16	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	18.35	8.17	1.00	0.00	2.22	0.07	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	11.60	1.93	0.77	0.00	1.16	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	10.31	1.72	0.00	0.00	1.15	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	168.54	50.19	5.04	2.58	4.31	1.72	0.12
Urethra, donor2	10319-105A4	75.53	8.99	12.59	0.00	3.60	1.80	0.00
Urothelial Cells, donor1	11520-119H8	13.81	6.11	0.80	2.13	0.80	0.00	1.06
Urothelial Cells, donor2	11600-120H7	6.01	2.40	0.00	0.40	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	7.11	4.58	0.23	0.69	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	17.83	10.03	1.11	2.45	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	72.96	10.68	0.00	0.00	3.56	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	47.18	10.01	1.43	0.00	2.86	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	30.12	13.01	0.68	0.00	2.05	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	45.80	13.77	2.75	0.00	3.10	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	65.66	10.46	2.32	0.00	1.74	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	47.90	14.58	0.00	0.00	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	68.83	17.44	0.00	0.00	4.59	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	49.30	10.04	0.00	0.00	5.48	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	5.55	2.47	0.25	0.00	1.48	0.25	0.00
Wilms' tumor cell line:HFWT	10597-108E3	191.85	42.24	6.16	6.16	6.16	3.52	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	15.36	10.33	0.28	0.00	2.23	0.00	0.00
achilles tendon, donor2	10292-104G4	115.73	24.80	14.47	0.00	6.20	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	41.56	24.99	0.00	5.61	3.82	0.00	2.80
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	74.99	24.15	3.02	0.00	6.50	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	72.06	21.84	7.12	0.00	2.73	0.95	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	47.08	32.93	2.18	5.44	2.72	1.09	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	4.50	3.94	0.28	0.00	0.00	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	44.41	8.88	2.33	0.00	1.90	0.85	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	262.41	119.23	2.18	0.00	5.99	1.36	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	25.56	9.69	0.88	0.00	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	61.25	27.77	3.68	0.00	6.94	1.63	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	84.26	55.91	5.44	0.00	6.21	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	3.13	0.74	0.00	0.00	0.55	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	15.60	0.00	0.00	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	74.83	29.74	3.72	0.00	3.25	1.39	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	74.05	47.38	1.04	0.00	8.03	0.52	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	54.65	37.70	0.88	0.00	4.68	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	33.00	6.51	1.39	0.00	5.11	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	42.77	41.54	6.99	0.00	0.41	5.76	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	42.05	11.66	0.31	0.31	3.38	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	31.58	5.12	0.43	0.85	1.28	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	32.45	10.01	2.73	0.61	2.12	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	29.85	8.91	2.65	0.00	2.89	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	40.98	25.61	1.56	0.00	2.00	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	20.01	7.67	0.67	0.00	1.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	3.72	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	24.86	14.31	0.75	0.38	3.01	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	91.15	20.06	3.93	0.00	4.80	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	7.50	1.87	0.00	0.00	5.62	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	65.94	11.54	1.41	0.24	9.89	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	220.73	47.16	15.36	1.40	6.98	4.03	0.16
adipose, donor1	10184-103D4	161.85	269.75	2.35	0.59	8.80	0.59	0.00
adipose, donor2	10185-103D5	147.20	197.89	2.84	4.46	12.17	0.00	1.22
adipose, donor3	10186-103D6	205.03	148.12	7.08	4.36	9.26	1.63	2.18
adipose, donor4	10187-103D7	381.37	177.68	0.00	0.87	6.07	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	19.57	2.53	0.00	0.00	11.05	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	72.75	14.55	3.64	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	51.09	16.41	0.67	0.00	4.27	0.13	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	59.67	42.52	2.14	0.71	2.50	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	201.48	49.85	7.65	0.00	5.33	1.16	0.23
amniotic membrane cells, donor2	12236-129G4	91.96	27.05	3.72	0.00	4.06	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	292.83	60.39	4.42	0.59	5.01	1.47	0.00
amygdala - adult, donor10196	10167-103B5	526.49	234.79	43.87	52.18	39.13	21.34	9.49
amygdala, adult, donor10252	10151-102I7	738.28	238.45	69.95	68.74	23.52	10.95	10.34
amygdala, newborn, donor10223	10360-105E9	311.47	107.80	15.49	75.21	14.20	6.13	15.82
anaplastic carcinoma cell line:8305C	10428-106D5	26.99	14.77	1.66	0.51	2.55	0.51	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	11.03	19.86	0.44	7.50	0.22	0.00	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	44.09	16.03	1.67	0.00	4.01	0.33	0.00
aorta, adult, pool1	10052-101G7	143.77	51.39	20.40	9.41	5.30	3.14	0.59
appendix, adult	10189-103D9	130.80	28.72	5.82	3.49	6.21	2.33	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	99.05	85.64	2.41	42.65	4.47	0.00	9.29
artery, adult	10190-103E1	107.34	50.27	4.08	1.36	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	54.18	49.54	12.31	21.30	5.36	2.17	5.22
b cell line:RPMI1788	10427-106D4	51.75	14.57	0.45	0.15	7.88	0.15	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	140.67	48.83	5.83	7.21	3.33	2.22	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	27.78	15.08	1.49	13.30	1.49	0.40	1.29
bile duct carcinoma cell line:TFK-1	10496-107C1	14.73	9.21	0.00	0.00	1.17	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	105.14	93.39	2.24	0.00	4.47	1.68	0.00
bladder, adult, pool1	10011-101C2	126.78	24.77	13.36	2.28	3.91	2.50	0.22
blood, adult, pool1	10053-101G8	48.72	31.00	0.00	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	74.50	38.54	10.28	13.70	0.86	5.14	0.00
bone marrow, adult	10192-103E3	95.15	35.09	2.70	0.00	4.05	0.67	0.00
brain, adult, donor1	10084-102B3	888.73	255.24	64.58	51.25	26.65	23.58	7.18
brain, adult, pool1	10012-101C3	936.97	235.30	104.45	48.44	36.08	26.73	9.02
brain, fetal, pool1	10085-102B4	731.96	382.01	42.74	392.70	8.01	26.71	88.16
breast carcinoma cell line:MCF7	10482-107A5	22.46	7.60	0.00	1.32	1.32	0.00	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	16.98	3.99	0.12	0.00	2.62	0.00	0.00
breast, adult, donor1	10080-102A8	231.71	27.78	5.05	5.68	2.53	1.89	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	2.92	2.79	0.38	0.13	1.27	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	39.58	29.07	1.24	4.95	4.33	0.00	2.78
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	22.79	11.74	0.46	1.38	6.68	0.00	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	4.12	5.57	0.24	0.73	1.21	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	95.44	96.85	1.88	11.75	6.11	0.00	2.35
carcinoid cell line:NCI-H727	10735-110B6	60.05	12.25	1.09	12.80	3.28	0.11	1.75
carcinoid cell line:SK-PN-DW	10719-109I8	153.38	189.19	3.49	52.92	8.87	0.63	8.24
carcinosarcoma cell line:JHUCS-1	10642-109A3	153.58	95.29	9.32	21.29	7.72	2.13	2.66
caudate nucleus - adult, donor10196	10177-103C6	536.52	149.67	37.99	14.97	21.88	20.72	3.45
caudate nucleus, adult, donor10252	10164-103B2	426.18	129.51	55.38	43.84	17.74	9.37	5.86
caudate nucleus, adult, donor10258	10379-105H1	411.87	133.72	19.10	32.86	25.22	8.41	3.82
caudate nucleus, newborn, donor10223	10354-105E3	455.96	115.36	17.95	24.90	21.61	5.86	4.76
cerebellum - adult, donor10196	10173-103C2	774.93	122.36	142.75	20.39	14.57	37.87	2.91
cerebellum, adult, donor10252	10166-103B4	685.37	127.04	130.03	11.53	18.79	27.54	1.92
cerebellum, adult, pool1	10083-102B2	592.96	147.98	70.71	4.48	18.97	20.35	1.03
cerebellum, newborn, donor10223	10357-105E6	618.56	106.28	40.68	9.13	13.28	8.30	1.66
cerebral meninges, adult	10188-103D8	282.14	167.17	23.70	46.39	9.33	5.55	12.61
cerebrospinal fluid, donor2	10294-104G6	135.21	42.39	10.23	3.65	3.65	2.19	0.00
cervical cancer cell line:D98-AH2	10552-107I3	31.06	17.54	4.60	0.00	1.87	0.72	0.00
cervical cancer cell line:ME-180	10553-107I4	6.13	3.65	0.33	0.33	0.83	0.00	0.00
cervix, adult, pool1	10013-101C4	94.81	28.77	12.81	0.84	3.25	3.57	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	42.22	20.62	4.60	0.56	5.57	0.98	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	32.66	3.92	0.00	10.45	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	28.58	8.70	0.12	0.37	3.23	0.00	0.12
choriocarcinoma cell line:SCH	10785-110H2	6.65	5.42	0.00	0.25	0.99	0.00	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	2.37	2.61	0.00	0.00	0.24	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	91.46	19.66	3.70	0.85	2.85	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	58.96	17.70	7.26	0.60	2.68	0.89	0.10
chorionic membrane cells, donor3	12240-129G8	88.47	20.88	4.40	3.85	3.85	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	63.62	142.38	3.03	0.00	1.01	2.02	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	6.72	6.34	0.38	0.00	1.15	0.38	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	9.08	5.28	0.21	0.00	0.63	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.51	0.51	0.00	0.00	0.26	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1.45	0.97	0.00	0.00	0.73	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	2.24	0.00	0.00	0.00	0.81	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	2.36	0.59	0.00	0.00	0.59	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	18.50	2.35	0.26	0.00	2.87	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	42.52	46.63	0.69	3.43	9.14	0.00	3.43
clear cell carcinoma cell line:TEN	10636-108I6	48.76	8.15	1.21	0.17	3.64	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	46.49	23.98	5.13	0.00	5.13	0.55	0.00
colon carcinoma cell line:COLO-320	10420-106C6	39.53	9.88	6.08	0.00	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	96.39	34.51	5.95	1.19	2.38	2.38	0.00
colon, adult, pool1	10014-101C5	91.18	24.68	7.17	2.12	3.41	1.53	0.35
colon, fetal, donor1	10070-101I7	152.03	46.35	6.18	8.65	2.47	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	0.00	4.58	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	70.54	32.29	0.00	2.12	2.55	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	90.86	39.24	4.23	1.66	4.53	0.60	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	108.44	44.84	5.50	1.83	2.82	0.71	0.42
corpus callosum, adult, pool1	10042-101F6	1105.40	223.23	164.41	12.49	37.26	55.39	3.65
cruciate ligament, donor2	10295-104G7	187.22	38.09	21.88	1.62	4.05	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	163.72	31.30	16.85	1.61	2.41	3.21	0.00
diencephalon, adult	10193-103E4	518.61	334.54	53.76	14.64	13.92	18.96	3.12
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	66.36	23.65	0.92	0.00	6.43	0.46	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	7.44	6.41	0.00	2.31	1.28	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	36.11	49.35	2.89	27.20	2.41	0.72	3.85
ductus deferens, adult	10196-103E7	74.75	19.44	4.49	1.99	1.99	1.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	92.17	46.09	7.20	2.88	5.76	1.44	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	122.85	60.32	5.89	2.94	3.68	3.68	2.21
dura mater, adult, donor1	10041-101F5	140.40	29.57	15.36	6.11	6.52	4.29	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	5.11	6.00	0.00	4.00	0.89	0.22	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	28.23	32.10	0.86	18.63	1.43	0.29	1.86
embryonic pancreas cell line:1B2C6	10604-108F1	81.39	14.80	0.62	11.10	3.08	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	36.93	18.47	2.72	1.21	2.42	0.00	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	67.00	13.28	1.54	9.26	1.54	0.31	1.54
embryonic pancreas cell line:2C6	10603-108E9	38.09	15.76	5.25	9.19	2.63	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	18.77	11.73	0.34	5.36	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	84.27	46.58	5.44	0.91	12.87	1.99	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	7.24	3.38	0.00	0.80	0.80	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	13.23	5.22	0.22	0.00	1.45	0.33	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	22.11	5.83	0.55	0.00	3.41	0.00	0.00
epididymis, adult	10197-103E8	76.61	25.33	6.28	1.05	3.14	1.67	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	240.39	124.90	12.60	30.69	12.42	2.31	8.34
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	112.07	61.74	2.36	16.12	2.75	0.39	3.54
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	62.12	34.86	3.93	1.31	2.36	0.52	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	64.17	26.47	6.99	1.48	2.85	0.59	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	48.40	30.25	4.15	1.34	2.91	0.22	0.11
esophagus, adult, pool1	10015-101C6	72.09	21.66	6.58	2.12	1.59	2.97	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	6.76	2.50	0.25	0.50	1.13	0.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	183.51	101.41	26.56	0.00	7.24	14.49	0.00
eye - muscle lateral, donor2	10298-104H1	73.65	21.04	10.52	2.10	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	107.15	16.37	14.88	0.00	5.95	1.49	0.00
eye - muscle superior, donor2	10297-104G9	132.99	38.98	12.61	1.15	2.29	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	81.61	10.20	2.91	1.46	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	238.47	97.88	18.05	13.73	7.88	2.29	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	17.05	15.00	1.15	3.85	1.41	0.38	1.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	48.20	28.02	0.71	0.47	5.46	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	602.54	127.23	98.89	63.52	26.36	21.67	13.98
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	17.11	7.51	1.20	2.10	1.20	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	5.94	1.65	0.09	0.09	1.37	0.00	0.00
gall bladder, adult	10198-103E9	97.30	36.94	9.90	3.38	3.86	4.35	0.24
gamma delta positive T cells, donor1	11937-126A2	34.90	12.35	1.61	0.00	1.61	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	60.51	17.55	0.75	0.00	1.87	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	35.06	27.25	1.69	9.08	1.06	0.21	1.90
gastric adenocarcinoma cell line:MKN45	10612-108F9	12.38	7.93	1.16	2.71	0.39	0.39	0.97
gastric cancer cell line:AZ521	10549-107H9	7.21	4.75	0.00	0.00	3.77	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	25.63	9.15	0.00	0.92	5.49	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	35.41	13.48	0.69	8.68	2.06	0.00	1.83
giant cell carcinoma cell line:LU65	10487-107B1	8.15	5.28	0.00	0.00	1.26	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	15.40	9.10	0.28	9.94	2.52	0.00	1.26
glassy cell carcinoma cell line:HOKUG	10688-109F4	5.24	3.74	0.00	0.25	0.75	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	52.78	27.76	3.38	9.50	4.12	0.84	1.37
glioblastoma cell line:A172, tech_rep2	10444-106F3	59.97	27.67	4.21	8.85	4.21	0.56	1.54
glioblastoma cell line:T98G	10485-107A8	63.69	45.69	12.69	1.21	3.53	2.87	0.11
glioma cell line:GI-1	10413-106B8	102.80	21.38	7.91	0.29	4.69	1.46	0.00
globus pallidus - adult, donor10196	10175-103C4	751.51	295.94	96.22	13.85	31.34	24.78	3.64
globus pallidus, adult, donor10252	10161-103A8	906.57	309.76	93.00	16.35	24.65	32.22	0.98
globus pallidus, adult, donor10258	10367-105F7	346.41	722.94	49.29	13.69	16.43	17.80	1.37
globus pallidus, newborn, donor10223	10364-105F4	334.67	104.98	7.99	19.72	4.80	5.86	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	22.02	0.00	2.45	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	10.45	0.00	0.00	5.23	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	64.96	40.96	3.52	12.48	2.24	0.32	1.60
hIPS +CCl2, biol_rep1	14383-156B9	103.76	35.81	1.84	2.75	10.56	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	83.22	48.01	0.46	2.74	6.86	1.37	0.46
hIPS +CCl2, biol_rep3	14385-156C2	72.14	59.26	0.64	0.64	9.66	0.00	0.00
hIPS, biol_rep1	14380-156B6	43.12	102.05	0.00	1.44	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	60.36	85.73	1.37	1.37	12.35	0.00	1.37
hIPS, biol_rep3	14382-156B8	353.11	219.59	9.93	43.04	23.17	15.45	8.83
hairy cell leukemia cell line:Mo	10712-109I1	31.61	22.99	0.57	0.00	2.30	0.00	0.00
heart - mitral valve, adult	10205-103F7	218.55	59.20	17.64	6.28	5.08	7.47	0.90
heart - pulmonic valve, adult	10206-103F8	108.25	28.76	11.77	2.61	3.14	3.92	1.31
heart - tricuspid valve, adult	10207-103F9	229.81	99.92	5.83	5.83	6.66	4.16	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	93.66	26.94	9.39	0.41	5.71	2.04	0.00
heart, adult, diseased, donor1	10051-101G6	175.02	58.76	22.57	1.28	6.39	2.13	0.00
heart, adult, pool1	10016-101C7	195.71	53.12	4.83	2.30	3.91	1.61	0.00
heart, fetal, pool1	10046-101G1	136.15	16.22	11.81	1.13	4.83	2.98	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	104.59	52.45	4.63	3.39	5.55	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	28.54	7.14	1.19	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	109.61	34.70	5.75	0.00	6.63	1.33	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	101.95	29.13	5.10	0.00	8.13	0.24	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	118.74	34.86	6.27	0.00	8.19	1.52	0.00
hepatoma cell line:Li-7	10484-107A7	86.30	56.05	5.00	15.57	2.67	1.56	2.34
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	27.74	17.09	2.21	0.00	4.22	0.20	0.00
hippocampus - adult, donor10196	10169-103B7	517.64	309.45	75.71	38.80	20.82	19.87	4.73
hippocampus, adult, donor10252	10153-102I9	803.54	257.57	81.84	51.43	23.88	13.06	5.51
hippocampus, adult, donor10258	10374-105G5	223.58	282.84	8.47	57.76	32.37	12.45	11.45
hippocampus, newborn, donor10223	10363-105F3	280.57	106.45	15.16	63.09	7.05	7.05	14.80
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	170.90	143.43	0.61	1.22	10.99	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	131.75	83.45	0.00	0.59	13.35	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	150.56	93.94	0.51	1.27	14.47	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	186.64	117.28	3.38	1.13	15.79	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	270.09	102.51	3.87	1.55	17.04	1.03	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	192.08	89.59	3.04	2.28	12.53	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	208.16	111.82	7.88	8.47	10.51	2.04	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	242.79	123.01	9.69	9.69	17.45	1.94	3.23
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	176.00	139.72	7.09	5.42	11.26	1.25	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	186.83	86.43	11.13	8.52	11.13	2.60	5.21
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	250.88	191.25	14.46	13.98	10.77	3.86	4.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	209.40	96.28	11.45	7.41	11.45	0.67	4.71
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	180.11	99.21	0.94	1.56	14.71	0.16	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	209.29	141.98	0.49	0.00	18.18	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	226.92	150.11	0.87	0.87	18.33	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	249.90	107.10	5.15	1.15	17.37	0.38	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	193.62	126.46	6.54	0.00	18.32	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	187.91	108.95	2.50	0.50	10.49	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	176.52	77.62	3.39	7.35	11.68	0.57	2.26
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	187.34	116.86	6.82	10.00	12.73	2.27	3.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	154.11	114.33	2.51	6.89	9.40	0.31	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	177.84	133.91	9.80	8.49	9.14	2.12	4.08
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	155.32	111.77	6.39	6.97	7.26	0.58	3.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	157.53	136.31	5.98	9.27	5.98	2.09	3.89
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	161.84	109.37	1.11	0.92	12.56	0.00	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	146.07	111.26	1.14	0.00	11.70	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	149.44	136.38	0.82	2.45	11.02	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	184.49	81.33	2.82	2.82	12.67	0.00	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	157.42	92.17	3.17	0.95	10.77	0.32	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	157.36	86.85	3.03	0.91	8.17	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	144.28	83.77	7.76	7.24	10.34	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	148.77	114.24	5.98	2.66	11.95	0.66	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	104.92	61.31	2.05	7.18	4.87	0.26	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	157.99	90.50	6.39	7.41	7.16	1.79	2.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	165.07	127.21	9.84	4.54	11.36	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	145.18	126.02	4.70	5.71	7.39	2.69	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	139.11	107.23	0.97	0.72	14.25	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	160.88	116.32	0.45	0.89	11.59	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	137.56	125.85	0.98	0.00	15.12	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	188.57	93.52	2.75	0.61	18.03	0.31	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	491.24	390.39	13.01	6.51	26.03	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	244.57	128.74	5.63	0.99	16.22	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	204.69	99.61	7.11	7.11	17.51	0.55	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	144.75	91.92	3.98	8.32	7.60	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	154.45	102.85	2.14	7.12	10.68	0.71	2.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	177.81	168.27	5.97	16.71	8.35	1.19	8.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	225.48	61.21	19.77	14.49	10.56	3.52	7.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	160.83	180.76	8.08	11.58	10.24	1.62	4.85
immature langerhans cells, donor1	11904-125F5	167.57	39.71	5.81	0.00	6.54	1.70	0.00
immature langerhans cells, donor2	11905-125F6	286.75	43.57	1.58	0.00	17.43	5.54	0.00
insula, adult, pool1	10039-101F3	635.65	125.20	98.32	82.14	30.38	22.62	19.49
keratoacanthoma cell line:HKA-1	10791-110H8	5.85	5.85	0.00	0.00	1.95	0.33	0.00
kidney, adult, pool1	10017-101C8	67.59	20.13	3.20	10.81	1.80	0.80	0.90
kidney, fetal, pool1	10045-101F9	82.27	9.69	6.08	1.20	4.88	1.34	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	30.53	17.18	0.43	11.79	1.14	0.14	1.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	83.91	61.24	8.85	8.71	2.21	4.56	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	61.66	38.72	2.94	20.55	5.32	0.37	1.65
left atrium, adult, donor1	10079-102A7	149.83	33.24	13.08	1.63	1.63	1.63	0.00
left ventricle, adult, donor1	10078-102A6	122.37	33.37	13.15	1.01	3.03	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	0.27	1.37	0.00	0.27	0.00	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	37.36	33.77	3.59	10.42	0.36	0.72	0.72
leiomyoma cell line:15242A	10570-108B3	37.50	27.17	0.54	2.17	1.09	0.54	0.54
leiomyoma cell line:15425	10571-108B4	20.88	11.90	0.97	0.97	0.73	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	19.05	6.35	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	17.77	15.68	1.05	12.55	2.09	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	2.36	0.59	0.00	0.35	0.35	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	31.09	11.56	2.34	0.31	2.19	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	75.78	48.49	14.74	5.97	3.66	2.07	1.22
liver, adult, pool1	10018-101C9	26.74	5.19	2.11	0.49	1.30	1.78	0.00
liver, fetal, pool1	10086-102B5	30.10	12.23	0.00	0.00	2.82	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	947.57	206.34	52.79	37.04	29.75	12.98	4.67
locus coeruleus, adult, donor10252	10165-103B3	660.88	261.51	75.67	37.46	21.41	19.56	4.98
locus coeruleus, adult, donor10258	10375-105G6	706.76	372.42	50.78	31.88	39.22	21.16	7.90
locus coeruleus, newborn, donor10223	10362-105F2	475.30	121.14	21.87	34.91	16.40	10.94	4.21
lung adenocarcinoma cell line:A549	10499-107C4	131.75	50.65	5.81	15.36	8.17	1.25	3.74
lung adenocarcinoma cell line:PC-14	10408-106B3	14.48	2.07	0.00	1.38	2.07	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	5.54	3.03	0.00	4.61	0.79	0.00	1.32
lung, adult, pool1	10019-101D1	214.99	41.58	13.94	12.88	7.21	3.54	0.83
lung, fetal, donor1	10068-101I5	440.10	75.92	11.99	3.71	15.98	10.85	0.86
lung, right lower lobe, adult, donor1	10075-102A3	287.30	90.73	21.08	12.37	9.16	7.79	0.00
lymph node, adult, donor1	10077-102A5	85.68	15.62	6.63	0.95	4.26	3.31	0.00
lymphangiectasia cell line:DS-1	10727-110A7	30.47	15.34	0.00	8.77	4.16	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	26.41	7.24	0.15	0.00	2.87	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	8.49	4.25	0.00	0.00	1.70	0.00	0.00
mature adipocyte, donor1	12231-129F8	31.97	11.10	2.66	0.00	1.78	0.00	0.00
mature adipocyte, donor2	12232-129F9	47.11	9.55	4.15	0.42	0.83	0.83	0.00
mature adipocyte, donor3	12233-129G1	28.68	7.35	2.13	0.24	1.42	0.24	0.00
mature adipocyte, donor4	12234-129G2	31.59	6.84	1.32	0.26	1.32	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	5.96	0.95	0.00	0.00	0.48	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	679.07	329.38	63.17	51.89	45.12	19.18	4.51
medial frontal gyrus, adult, donor10252	10150-102I6	960.54	230.43	89.56	51.31	30.16	15.82	8.64
medial frontal gyrus, adult, donor10258	10368-105F8	752.92	331.03	55.91	56.23	37.17	14.30	10.48
medial frontal gyrus, newborn, donor10223	10352-105E1	413.69	147.99	31.99	67.39	8.10	5.54	23.46
medial temporal gyrus - adult, donor10196	10183-103D3	1341.74	135.34	79.31	73.91	37.46	17.21	12.32
medial temporal gyrus, adult, donor10252	10156-103A3	829.16	240.03	91.68	41.60	25.68	16.34	7.22
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	277.38	697.31	21.19	23.12	13.48	7.71	15.41
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	2856.37	2497.53	315.78	57.41	14.35	57.41	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	426.77	144.65	19.74	97.99	11.13	5.38	25.13
medulla oblongata - adult, donor10196	10174-103C3	563.96	245.96	64.25	14.93	26.61	16.87	1.30
medulla oblongata, adult, donor10252	10155-103A2	604.82	179.11	64.24	22.91	17.96	18.42	3.41
medulla oblongata, adult, pool1	10038-101F2	553.92	136.48	83.34	34.12	27.26	27.92	5.71
medulla oblongata, newborn, donor10223	10361-105F1	627.70	217.68	15.62	27.08	21.87	12.50	6.25
medulloblastoma cell line:D283 Med	10838-111E1	18.82	11.51	0.00	19.26	1.33	0.00	1.55
medulloblastoma cell line:ONS-76	10759-110E3	67.86	22.74	7.21	0.00	2.20	1.71	0.00
melanoma cell line:COLO 679	10514-107E1	6.04	4.02	1.29	0.43	0.14	0.29	0.00
melanoma cell line:G-361	10465-106H6	18.46	14.93	1.90	0.27	1.90	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	24.60	21.89	1.45	9.41	0.72	0.18	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	136.58	50.23	7.05	0.00	7.93	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	145.17	42.25	4.67	0.52	5.70	0.52	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	128.88	48.33	5.37	1.23	3.53	1.84	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	80.53	21.45	4.00	1.45	1.64	1.09	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	151.98	54.66	3.31	3.73	4.14	0.83	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	64.34	19.95	4.35	10.96	1.97	0.70	1.55
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	63.55	24.07	2.89	5.58	0.77	0.39	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	125.63	72.18	2.08	7.63	0.69	0.69	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	101.78	27.46	3.95	9.61	2.57	1.03	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	205.07	50.49	4.72	10.24	6.10	1.61	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	150.81	36.61	6.23	1.86	5.17	1.86	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	123.97	43.21	5.67	2.84	5.00	2.30	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	117.22	29.31	5.98	1.99	3.56	1.42	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	71.47	39.52	0.66	0.33	5.93	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	79.29	19.79	2.35	2.21	4.57	0.55	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	168.96	121.13	2.44	17.11	6.98	1.40	2.79
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	87.79	25.32	3.27	3.47	3.47	1.02	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	49.25	36.66	1.80	1.08	3.95	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	57.52	20.38	1.55	3.83	2.69	0.31	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	40.58	32.15	1.60	4.10	2.96	1.14	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	134.68	37.34	6.71	3.36	8.39	2.94	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	57.09	17.48	3.89	0.00	2.69	1.34	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	98.47	33.79	2.98	6.04	3.15	1.14	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	101.98	29.82	2.21	0.74	5.15	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	53.23	26.04	2.00	0.57	1.72	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	53.05	57.68	4.63	3.79	1.68	0.84	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	129.69	55.26	7.76	0.00	3.65	2.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	150.15	86.71	9.46	0.51	4.35	3.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	143.44	71.46	10.99	1.05	6.02	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	138.95	83.18	10.17	1.54	4.01	3.08	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	143.80	75.55	10.36	1.18	4.71	3.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	145.87	77.84	6.77	0.34	5.08	4.74	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	137.54	96.28	9.43	0.39	3.93	1.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	137.63	81.56	10.19	0.46	3.24	2.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	48.30	0.00	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	167.57	62.30	11.54	1.15	7.21	4.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	152.60	64.70	11.60	1.12	5.80	2.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	152.86	72.83	7.69	0.48	5.29	4.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	235.40	38.87	8.07	0.73	2.20	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	148.36	57.73	11.08	0.34	4.03	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	152.70	62.63	4.91	1.64	6.96	5.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	159.37	61.00	8.16	1.72	4.73	3.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	158.60	106.64	0.00	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	160.11	103.30	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	165.64	93.21	11.04	0.65	7.15	5.85	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	224.07	138.22	7.27	1.45	5.82	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	239.89	130.60	6.93	0.00	7.46	5.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	192.99	131.66	10.63	0.00	2.45	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	211.85	124.78	6.22	0.00	5.05	3.11	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	186.79	205.68	6.30	0.00	6.30	6.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	200.68	127.16	9.93	0.00	7.95	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	171.62	123.95	4.77	0.00	9.53	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	201.61	97.84	7.12	0.00	7.71	4.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	253.44	124.28	13.40	0.00	3.66	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	162.31	135.26	0.00	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	255.89	133.64	6.33	0.00	6.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	266.96	152.79	6.90	0.34	3.45	4.83	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	240.71	229.96	4.30	0.00	6.45	6.45	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	139.71	299.38	3.99	11.98	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	96.43	161.86	0.00	10.33	0.00	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	82.31	106.35	4.48	1.22	2.85	1.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	121.55	123.14	7.94	1.59	3.97	3.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	69.56	90.79	1.77	2.95	2.95	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	87.90	92.89	3.74	1.87	2.81	3.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	77.53	135.00	5.35	2.67	4.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	61.50	55.59	3.55	1.18	1.18	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	64.20	100.15	0.00	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	54.38	55.07	7.57	0.00	1.38	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	58.88	66.80	2.47	0.49	1.98	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	72.90	56.08	4.49	0.00	4.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	74.42	78.24	1.91	1.27	5.09	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	78.98	85.43	3.63	0.40	4.43	0.81	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	80.68	106.85	2.18	2.18	8.72	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	96.30	89.96	6.34	0.00	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	67.36	31.56	4.25	1.82	2.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	85.86	103.94	0.00	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	79.90	81.54	3.29	0.82	2.47	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	120.05	57.74	5.16	0.60	3.57	2.18	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	83.07	88.59	3.24	0.65	2.60	0.97	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	86.58	116.12	6.11	2.04	2.04	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	79.69	11.61	5.42	7.74	0.00	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	106.07	47.96	0.94	10.87	12.05	0.00	6.38
mesothelioma cell line:ACC-MESO-4	10494-107B8	32.67	24.09	1.16	3.24	2.32	0.00	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	72.65	72.65	0.00	17.09	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	67.40	25.89	2.77	18.60	1.44	0.72	1.44
mesothelioma cell line:Mero-25	10850-111F4	8.40	15.66	1.13	5.67	0.00	1.13	1.59
mesothelioma cell line:Mero-41	10851-111F5	22.98	17.60	0.98	11.00	2.93	0.00	0.98
mesothelioma cell line:Mero-48a	10852-111F6	22.59	23.25	0.89	11.29	1.11	0.22	1.55
mesothelioma cell line:Mero-82	10853-111F7	42.05	50.98	3.94	15.51	0.53	1.84	2.37
mesothelioma cell line:Mero-83	10854-111F8	29.62	24.00	0.85	11.23	0.85	0.17	1.70
mesothelioma cell line:Mero-84	10855-111F9	119.06	69.51	2.53	8.59	4.04	0.25	1.52
mesothelioma cell line:Mero-95	10856-111G1	30.44	26.09	2.07	15.53	0.62	1.66	2.48
mesothelioma cell line:NCI-H2052	10847-111F1	35.45	23.85	2.48	6.63	1.99	0.66	0.66
mesothelioma cell line:NCI-H226	10846-111E9	22.26	26.42	0.54	17.56	3.26	0.18	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	39.29	27.67	4.61	3.59	3.25	0.51	0.34
mesothelioma cell line:NCI-H28	10845-111E8	25.70	17.05	0.25	10.18	0.25	0.00	2.54
mesothelioma cell line:No36	10857-111G2	48.60	31.32	0.65	5.87	2.94	0.00	0.98
mesothelioma cell line:ONE58	10858-111G3	21.95	23.30	0.81	8.94	0.54	0.00	1.35
migratory langerhans cells, donor1	11901-125F2	483.45	55.08	7.10	2.30	26.49	0.77	0.58
migratory langerhans cells, donor2	11902-125F3	354.50	54.83	3.79	1.59	23.69	0.49	0.73
migratory langerhans cells, donor3	11903-125F4	393.42	87.05	6.82	1.26	22.44	1.26	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	93.05	84.56	1.96	6.20	2.29	0.00	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	57.65	69.73	2.33	13.35	4.45	0.42	3.60
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	29.49	7.37	1.15	8.98	1.38	0.00	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	133.78	86.77	10.66	0.19	8.37	1.33	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	73.18	30.49	5.36	0.00	6.47	1.29	0.00
myeloma cell line:PCM6	10474-106I6	91.32	63.06	7.71	0.00	6.52	1.38	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	216.61	46.16	5.58	41.60	13.19	0.00	7.10
myxofibrosarcoma cell line:NMFH-1	10684-109E9	30.99	27.85	3.73	0.59	2.75	0.59	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.68	1.11	0.00	0.00	0.33	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	3.02	1.25	0.00	0.22	0.22	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	77.28	7.18	0.00	0.00	1.66	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	123.77	78.91	26.92	21.17	7.82	2.07	5.98
neuroblastoma cell line:NB-1	10539-107G8	188.02	88.30	20.02	19.27	8.04	2.81	7.30
neuroblastoma cell line:NBsusSR	10607-108F4	52.30	39.65	3.80	10.54	1.27	1.27	1.27
neuroblastoma cell line:NH-12	10555-107I6	124.11	108.08	9.88	50.50	6.15	0.56	8.39
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	93.70	59.31	6.88	28.47	0.95	0.95	3.56
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	612.77	436.50	24.07	79.03	11.88	6.34	7.13
neuroectodermal tumor cell line:TASK1	10774-110F9	69.03	77.48	1.61	8.05	4.43	1.01	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	226.33	66.12	1.91	48.32	10.81	1.27	10.17
neurofibroma cell line:Hs 53.T	10729-110A9	170.35	155.18	7.45	11.71	7.45	1.60	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	100.80	14.54	4.90	0.00	7.78	1.01	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	75.25	32.82	5.60	18.41	1.60	0.80	4.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	90.41	72.14	13.14	6.41	4.17	4.49	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	88.55	112.99	6.31	8.93	1.05	3.15	0.53
nucleus accumbens, adult, pool1	10037-101F1	484.82	113.14	77.15	52.31	25.40	18.09	12.28
occipital cortex - adult, donor10196	10172-103C1	883.90	156.59	63.87	26.78	45.33	30.91	2.06
occipital cortex, adult, donor10252	10163-103B1	895.26	320.16	83.73	33.81	33.28	13.15	4.56
occipital cortex, newborn, donor10223	10355-105E4	507.34	96.81	16.01	67.69	17.47	6.19	32.75
occipital lobe, adult, donor1	10076-102A4	1064.81	316.19	85.02	53.53	26.50	30.18	11.55
occipital lobe, fetal, donor1	10073-102A1	1136.26	351.00	148.04	267.76	24.89	35.19	86.25
occipital pole, adult, pool1	10036-101E9	545.66	111.88	72.93	42.42	33.27	14.90	12.77
olfactory region, adult	10195-103E6	614.04	257.73	63.05	59.23	21.78	16.24	9.93
optic nerve, donor1	10277-104E7	1348.71	348.18	90.05	2.00	24.01	30.02	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	11.85	3.08	0.57	0.00	1.48	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	2.20	1.79	0.00	1.65	0.69	0.00	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	16.26	5.25	1.19	0.00	0.51	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	2.08	0.92	0.12	0.12	0.12	0.12	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	67.02	42.33	4.70	11.46	1.76	0.88	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	36.44	9.34	0.00	10.28	5.61	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	78.89	37.32	10.82	5.30	1.70	1.91	1.48
ovary, adult, pool1	10020-101D2	112.68	21.23	16.86	1.05	7.25	5.07	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	26.03	21.08	1.10	4.95	2.02	0.00	0.73
pancreas, adult, donor1	10049-101G4	43.27	24.46	1.88	0.94	0.94	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	7.55	9.22	0.00	0.00	1.12	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	153.32	111.41	8.01	25.72	2.21	2.04	2.21
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	5.46	3.97	0.17	9.11	0.33	0.00	1.82
paracentral gyrus, adult, pool1	10035-101E8	525.34	125.75	81.36	58.21	29.74	18.03	13.09
parietal cortex, adult, donor10258	10373-105G4	407.37	180.57	26.42	33.03	19.82	14.68	4.40
parietal lobe - adult, donor10196	10171-103B9	676.21	310.36	64.89	46.08	30.10	15.99	14.11
parietal lobe, adult, donor10252	10157-103A4	802.09	255.96	73.25	47.03	30.50	19.38	7.70
parietal lobe, adult, pool1	10034-101E7	546.69	118.26	91.56	61.07	27.93	20.27	12.42
parietal lobe, fetal, donor1	10072-101I9	1029.96	444.18	107.65	318.11	21.34	17.46	97.95
parietal lobe, newborn, donor10223	10356-105E5	472.56	122.25	24.67	80.01	17.57	5.98	25.05
parotid gland, adult	10199-103F1	34.53	15.42	1.23	0.62	1.85	1.23	0.00
penis, adult	10200-103F2	111.72	53.17	7.52	3.22	2.15	3.22	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	187.05	142.80	1.86	82.93	1.49	0.19	6.88
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	7.58	5.54	0.29	0.44	1.60	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	183.83	39.99	18.06	2.58	13.55	3.23	0.00
pineal gland, adult, donor10252	10160-103A7	498.64	69.88	34.35	1.18	15.40	1.78	0.59
pineal gland, adult, donor10258	10377-105G8	230.76	42.01	11.91	3.76	15.05	3.14	0.00
pituitary gland - adult, donor10196	10180-103C9	81.96	18.21	13.15	7.08	4.05	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	213.16	19.80	13.55	9.90	11.47	2.61	1.04
pituitary gland, adult, donor10258	10378-105G9	98.74	21.28	0.85	5.11	12.77	0.00	0.85
placenta, adult, pool1	10021-101D3	66.11	14.08	6.34	1.29	2.58	2.37	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	20.79	5.83	0.13	0.26	3.18	0.13	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	221.79	64.28	22.26	2.49	4.36	6.38	0.00
pons, adult, pool1	10033-101E6	457.45	125.83	73.67	56.29	27.20	24.53	14.55
postcentral gyrus, adult, pool1	10032-101E5	815.09	170.86	91.71	56.49	35.22	21.27	15.69
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	139.25	74.14	1.89	17.63	19.66	0.15	6.70
prostate cancer cell line:PC-3	10439-106E7	44.10	17.06	2.54	1.09	2.18	0.00	0.73
prostate, adult, pool1	10022-101D4	79.99	19.32	10.97	1.36	3.26	2.99	0.18
putamen, adult, donor10196	10176-103C5	438.84	160.52	59.49	42.26	18.41	12.98	8.97
putamen, adult, donor10252	10152-102I8	396.07	145.09	17.65	15.69	23.53	11.76	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	131.14	157.36	6.56	7.65	15.30	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	323.52	84.81	20.54	31.17	17.15	8.94	3.62
putamen, newborn, donor10223	10365-105F5	700.18	153.68	26.99	20.99	26.24	11.99	2.25
rectal cancer cell line:TT1TKB	10469-106I1	10.18	4.07	1.16	0.29	0.00	0.29	0.00
rectum, fetal, donor1	10067-101I4	248.99	79.29	16.69	13.91	4.17	2.78	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	18.87	6.36	1.48	5.51	2.54	0.00	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	14.50	13.25	0.00	6.63	0.41	0.41	1.66
retina, adult, pool1	10030-101E3	160.83	23.16	19.98	8.55	5.86	4.67	1.39
retinoblastoma cell line:Y79	10475-106I7	109.64	47.54	2.08	13.51	11.17	0.00	3.38
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.18	13.28	1.23	0.00	2.58	0.12	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	25.87	15.47	1.69	1.69	0.84	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	118.23	28.80	4.55	11.37	3.03	0.76	0.00
salivary acinar cells, donor1	11771-123I7	62.80	17.64	7.12	1.46	1.29	3.88	0.32
salivary acinar cells, donor2	11772-123I8	60.31	26.02	6.61	1.38	1.38	3.17	0.00
salivary acinar cells, donor3	11773-123I9	62.89	7.94	2.65	5.96	2.65	2.65	0.00
salivary gland, adult, pool1	10093-102C3	30.89	15.44	1.14	0.57	1.72	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	39.88	10.96	1.43	0.00	2.61	0.25	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	37.62	11.99	2.23	0.24	3.76	0.24	0.00
seminal vesicle, adult	10201-103F3	61.90	24.34	3.17	2.12	1.06	2.12	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	5.10	6.32	0.00	2.92	0.24	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	39.25	22.65	0.75	5.28	1.01	0.75	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	50.18	35.12	1.00	2.01	3.01	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	4.16	3.09	0.27	2.69	0.27	0.00	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	94.17	37.36	4.53	0.55	4.64	0.55	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	3.23	0.90	0.00	0.00	0.39	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	66.68	9.93	8.51	0.00	0.00	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	59.97	16.31	5.64	0.72	1.80	1.20	0.12
skeletal muscle, fetal, donor1	10066-101I3	125.63	34.17	11.06	0.00	1.01	3.02	1.01
skin, adult, donor1	10074-102A2	67.85	40.71	0.00	0.00	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	145.18	71.96	24.62	1.89	4.42	6.31	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	150.42	100.39	5.67	7.67	20.68	1.67	4.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	173.99	75.65	11.98	43.81	5.67	0.63	6.93
small cell lung carcinoma cell line:DMS 144	10841-111E4	9.06	8.29	0.00	0.39	2.89	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	44.83	12.86	0.82	2.14	3.46	0.16	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	110.34	40.21	0.32	36.51	9.33	0.16	4.99
small cell lung carcinoma cell line:WA-hT	10562-108A4	68.86	30.07	3.70	2.18	7.63	0.00	0.22
small intestine, adult, pool1	10024-101D6	56.97	19.59	8.48	1.79	1.79	0.72	0.48
small intestine, fetal, donor1	10064-101I1	67.08	35.13	11.30	1.72	2.46	1.97	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	64.11	32.83	2.56	0.00	3.59	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	104.16	19.13	16.54	1.29	4.14	3.36	0.52
somatostatinoma cell line:QGP-1	10781-110G7	23.32	8.04	1.07	2.41	1.61	0.54	0.27
spinal cord - adult, donor10196	10181-103D1	1506.51	169.30	106.90	21.11	34.64	25.69	1.61
spinal cord, adult, donor10252	10159-103A6	782.63	157.31	57.56	14.98	24.44	24.05	3.15
spinal cord, adult, donor10258	10369-105F9	455.20	367.34	29.06	6.23	24.21	23.52	3.46
spinal cord, fetal, donor1	10056-101H2	554.95	298.21	77.45	63.42	25.00	29.27	11.59
spinal cord, newborn, donor10223	10359-105E8	590.55	157.97	35.36	33.06	10.56	19.75	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	68.40	29.27	7.32	5.08	2.54	2.39	0.60
spleen, adult, pool1	10025-101D7	71.48	15.64	5.84	1.54	3.30	1.32	0.22
spleen, fetal, pool1	10044-101F8	107.90	12.40	6.59	0.72	6.04	1.51	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	131.77	29.40	0.83	0.00	14.28	0.10	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	7.22	5.51	0.38	3.23	1.14	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	35.99	15.03	5.24	0.35	3.84	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	4.30	1.95	0.00	0.00	0.39	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	37.82	16.32	2.48	0.23	3.26	0.11	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	9.32	3.81	0.42	1.27	0.85	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	23.27	10.58	0.00	6.35	0.85	0.42	1.27
stomach, fetal, donor1	10062-101H8	86.51	12.82	4.27	2.14	4.27	0.00	1.07
submaxillary gland, adult	10202-103F4	47.28	18.80	3.99	0.57	1.71	2.85	0.00
substantia nigra - adult, donor10196	10178-103C7	3473.55	32347.40	108.55	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	859.90	386.13	84.74	6.65	23.47	33.03	0.62
substantia nigra, adult, donor10258	10371-105G2	337.76	289.14	12.93	43.45	32.07	16.55	6.72
substantia nigra, newborn, donor10223	10358-105E7	615.43	195.72	20.49	17.66	14.84	12.72	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	72.68	27.51	2.06	1.83	5.73	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	829.31	166.24	86.64	74.77	37.81	20.18	18.14
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	842.61	428.78	133.91	393.17	30.63	32.05	136.76
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	672.05	444.81	59.34	268.12	22.42	14.50	101.53
tenocyte, donor1	11763-123H8	122.19	99.14	7.33	1.40	3.14	4.89	0.00
tenocyte, donor2	11765-123I1	103.39	148.41	9.54	12.97	2.67	3.05	1.14
tenocyte, donor3	11768-123I4	90.81	97.86	5.19	1.11	4.82	1.85	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	96.20	59.15	0.85	13.43	8.16	0.17	2.38
teratocarcinoma cell line:NCR-G1	10798-110I6	70.29	34.22	3.70	1.23	5.09	0.46	0.15
teratocarcinoma cell line:PA-1	10807-111A6	115.46	45.25	1.08	6.04	12.40	0.46	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	93.18	32.12	1.65	2.67	5.84	0.38	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	185.68	66.18	2.27	21.93	9.83	0.38	3.40
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	60.31	12.76	0.33	12.65	1.20	0.00	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	15.63	4.89	0.33	3.58	0.33	0.00	0.98
testis, adult, pool1	10026-101D8	100.50	22.87	14.82	2.36	5.58	3.54	0.43
testis, adult, pool2	10096-102C6	61.35	33.83	5.41	0.45	5.86	3.16	0.00
thalamus - adult, donor10196	10168-103B6	901.96	480.23	86.11	19.87	39.74	25.39	4.42
thalamus, adult, donor10252	10154-103A1	915.35	286.31	87.67	12.03	22.19	24.38	1.72
thalamus, adult, donor10258, tech_rep1	10370-105G1	281.75	606.61	18.48	18.48	21.55	1.54	6.16
thalamus, adult, donor10258, tech_rep2	10370-105G1	500.00	306.98	41.01	14.33	17.13	10.21	2.47
thalamus, newborn, donor10223	10366-105F6	363.03	174.90	15.53	54.66	17.26	8.63	10.93
throat, adult	10209-103G2	91.63	26.46	7.74	1.25	2.00	2.75	0.75
throat, fetal, donor1	10061-101H7	83.18	35.65	10.06	0.00	3.96	1.83	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	83.86	34.18	7.15	0.40	2.19	1.39	0.00
thymus, adult, pool1	10027-101D9	122.18	11.53	5.47	0.10	9.54	1.09	0.00
thymus, fetal, pool1	10043-101F7	80.53	7.59	2.91	0.00	5.51	0.94	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	25.79	9.57	0.40	0.80	1.86	0.53	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	56.99	48.33	1.40	43.72	3.21	0.42	1.82
thyroid, adult, pool1	10028-101E1	66.16	14.84	4.29	1.59	2.61	0.65	0.28
thyroid, fetal, donor1	10060-101H6	69.34	18.72	5.80	0.26	1.85	1.05	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	178.62	33.88	12.32	6.16	9.24	6.16	0.00
tongue, adult	10203-103F5	81.87	27.44	4.88	0.93	2.33	1.63	0.23
tongue, fetal, donor1	10059-101H5	87.49	50.05	9.06	0.00	2.36	0.79	0.00
tonsil, adult, pool1	10047-101G2	53.49	7.91	5.01	0.30	3.61	1.20	0.00
trachea, adult, pool1	10029-101E2	69.37	14.72	5.64	3.76	1.88	1.15	0.33
trachea, fetal, donor1	10058-101H4	105.02	53.86	12.69	1.54	5.39	2.31	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	63.42	51.72	3.90	1.06	3.90	1.06	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	45.19	14.59	2.84	2.13	3.85	0.10	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	67.22	36.82	0.94	9.87	3.76	0.31	1.72
tridermal teratoma cell line:HGRT	10694-109G1	123.66	15.22	5.71	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	63.66	35.72	12.11	9.99	1.69	2.20	1.69
umbilical cord, fetal, donor1	10057-101H3	95.98	43.82	25.04	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	119.44	23.38	6.65	0.51	6.48	4.44	0.34
uterus, fetal, donor1	10055-101H1	126.96	47.61	12.80	2.05	7.17	3.07	1.02
vagina, adult	10204-103F6	210.01	37.48	5.17	3.23	5.17	1.94	0.00
vein, adult	10191-103E2	105.65	28.06	4.82	1.75	2.63	3.51	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	39.25	25.10	0.00	0.00	4.27	0.00	0.00